Skip to content
Sign up

Updated · published

Patellar tendinopathy (jumper's knee)

Patellar tendinopathy (jumper's knee): an overuse tendinosis of jumping sports. Diagnosis, imaging, progressive loading and return to jumping.

The essentials, in 30 seconds

Pain that is very localised at the tip of the patella, proportional to load, in a jumping athlete suggests patellar tendinopathy: load management, not complete rest.

18.3%of athletes have patellar tendinopathy

What it is
A non-inflammatory overload condition (tendinosis) of the proximal patellar tendon.
What points to it
Pain that is very localised at the inferior pole of the patella, proportional to load, reproduced by the single-leg decline squat.
How it is confirmed
The diagnosis is essentially clinical.
What to do first
Education and load management, then progressive exercise (PTLE, HSR, isometrics): complete rest is harmful.
Who it affects
Particularly common in volleyball (24.8 %) and basketball (20.8 %), less so in football (6.1 %).

What follows covers each of these points in detail, with sources. It is there if you need it.

This topic is taught in a course: Return to sport, performance and prevention: private practice and patient self-management, on-site with Adrien Blachère.

Chapter by chapter

1 / 8

7 article chapters · 64 min in total

Chapter 1

Understand◔ 9 min

Prevalence reaches 24.8 % in volleyball players and 20.8 % in basketball players.

Definition
An overload tendinosis, non-inflammatory, painful at the inferior pole of the patella.
Sex and age
Affects men and adult athletes more than minors.
Risk factors
Poorly managed load and poor ankle dorsiflexion double the risk (Backman 2011).
Course
Without management, more than 50 % of athletes have to give up their sport (Kettunen 2002).
Chapter 2

Diagnose◔ 10 min

The VISA-P is the reference tool (0-100) for monitoring patellar tendinopathy.

Diagnostic triad
Localised pain, a dose-response relationship with load and reproduction on the SLDS form the triad.
Kinetic chain
Ankle dorsiflexion, strength and landing mechanics must be assessed systematically.
Red flags
Rupture, avulsion fracture, infection or true joint locking should raise the alarm.
Differentials
A meniscal lesion suspected on MRI may be a false positive in adolescents (Petrolo 2022).
Chapter 3

Treat◔ 14 min

4-phase PTLE did better than eccentric exercise in one trial, with no established superiority over HSR.

First line
Education, load modulation and progressive exercise for at least 12 weeks, despite low to very low certainty.
HSR
Three sessions a week of HSR, with no demonstrated difference from PTLE; the Dutch guideline prefers it.
PRP
PRP injections are not recommended routinely; the evidence is divergent across studies.
Corticosteroids
Intra- or peritendinous injections are contraindicated, with a risk of rupture.
Chapter 4

Recover◔ 7 min

Improvement is perceived at 4-8 weeks, peaks at 12-24 weeks, with return to competition at 3-12 months.

Patient tools
A jump logbook and a monthly VISA-P help maintain the programme over time.
Return to sport
No pain on the SLDS should objectively guide the return to sport.
Prognosis
Without management, more than 50 % of athletes give up their sport (Kettunen 2002).
Chapter 5

Kinetic chain◔ 5 min

A recalcitrant tendinopathy calls for the diagnosis to be reconsidered and the kinetic chain to be assessed.

Ankle
Measure with the knee-to-wall test and treat with mobilisations and calf stretching.
Hip
Weakness of the hip abductors and external rotators is associated with patellar tendinopathy: screen for it and strengthen (Mendonça 2018).
Landing
A “stiff-legged” landing is corrected with drop jumps and video feedback.
Persistent failure
After 6 months of failure, discuss ESWT or a specialist surgical opinion.
Chapter 6

Case studies◔ 11 min

In a marathon runner, lumbar extensions alone took the VISA-P from 57 to 99/100.

Petrolo case
In an adolescent footballer, a meniscal tear on MRI led the diagnosis astray.
Serres case
In a 45-year-old marathon runner, the pain stemmed from a lumbar derangement (MDT/McKenzie).
Level of evidence
A single case is level 5; when in doubt, follow the meta-analyses (level 1a).
Chapter 7

In practice◔ 8 min

Presenting PTLE and HSR to the patient and discussing their preferences increases adherence.

VISA-P follow-up
The VISA-P is measured at every follow-up, every 4 to 6 weeks.
Refractory cases
After 12 weeks of failure, reconsider the diagnosis and assess the kinetic chain.
VISA-P tool
The VISA-P has 8 questions scored from 0 to 100, with an MCID of 13 to 15 points.
8

Train on this

On-siteDPCFIFPL

Sports physiotherapy

Return to sport, performance and prevention: private practice and patient self-management

Adrien Blachère · Quentin Bouillard

Next comes practice: the course that teaches this topic, with Adrien Blachère.

Our courses on this topic may be covered by DPC or FIFPL, the French continuing-education funding schemes, depending on your profession and situation.

Posted by

Anthony BAILLON

Physiotherapist


Physiotherapy · Tendon disorders · Jumping sports

In brief

Patellar tendinopathy (jumper's knee) is a non-inflammatory overload condition (tendinosis) of the proximal patellar tendon, typical of jumping sports and repeated decelerations. The pain is very localised at the inferior pole of the patella and proportional to load, reproduced by the single-leg decline squat; imaging is not routine because structural abnormalities are common in asymptomatic athletes. The foundation of treatment is education and load management, with progressive exercise (PTLE protocol, Heavy Slow Resistance, isometrics), complete rest being harmful. Overall prevalence in athletes is 18.3 %, reaching 24.8 % in volleyball.

Clinical synthesis based on the most recent meta-analyses and international consensus statements: Cochrane Lopes 2025, the 2025 Dutch guideline, SR/MA Nutarelli 2023, NMAs Challoumas 2021 and 2023, NMA Liu 2026, RCT Breda 2021 (PTLE), the ICON 2019 terminology consensus.

Clinical diagnosis HSR & PTLE Return to sport Evidence-based
18.3%
Overall prevalence in athletes
Nutarelli 2023 · SR/MA OJSM
24.8%
Prevalence in volleyball (vs 20.8 % basketball)
Nutarelli 2023 · SR/MA OJSM
+28pts
VISA-P at 24 weeks with PTLE (vs +18 eccentric, one trial)
Breda 2021 · RCT BJSM

Clinical synthesis

  • Patellar tendinopathy is a non-inflammatory overload condition ("tendinosis") of the proximal patellar tendon, typical of jumping sports and repeated decelerations.
  • Overall prevalence in athletes: 18.3 % (Nutarelli 2023). By sport: volleyball 24.8 %, basketball 20.8 %, football 6.1 %. It preferentially affects men (17 %) and athletes > 18 years old (21.3 %).
  • The diagnosis is clinical : very localised pain at the inferior pole of the patella, proportional to load (jumps, decelerations), reproduced by the single-leg decline squat (Malliaras 2015).
  • The main risk factor is poor management of training load (Sprague 2018). An ankle dorsiflexion < 36.5° doubles the risk in junior basketball players (Backman 2011, AJSM, n=90).
  • The strength of the quadriceps and gluteals, landing mechanics and training load are modifiable factors to be assessed systematically (Sprague 2018, McAuliffe 2020).
  • The continuum model of Cook-Purdam (reactive → dysrepair → degenerative) remains the dominant teaching framework, but it is still conceptual: it guides load modulation more than it formally classifies.
  • Imaging is not routine. Structural abnormalities (thickening, hypoechogenicity, neovascularisation) are common in asymptomatic athletes: treat the patient, not the image.
  • The VISA-P score (Visentini 1998) remains the reference PROM tool (0-100). Typical MCID 13-15 points (Hernandez-Sanchez 2014).
  • The foundation of treatment is patient education and load management. Complete rest is harmful and should be avoided (Malliaras 2015, Cook 2009).
  • Progressive exercise is the first-line treatment, recommended despite low to very low certainty. The Breda 2021 PTLE (4 phases: isometric → isotonic → energy storage → sport-specific) did better than decline eccentric exercise at 24 weeks in a trial of 76 patients (+28 vs +18 VISA-P points); no protocol is established as superior to HSR (2026 NMA).
  • The Heavy Slow Resistance (HSR) protocol of Kongsgaard 2009 and isometrics (possible short-term analgesia, for an unestablished duration) are complementary components of a progressive rehabilitation.
  • Added to eccentric exercise, shockwave therapy (ESWT) has not demonstrated a benefit (Challoumas 2023); the 2025 Dutch guideline reserves adjuncts for specific cases only. Injections of corticosteroids are not recommended (Everhart 2017). For PRP, the evidence diverges: the Challoumas 2021 NMA keeps progressive exercise as first line without ranking PRP among the most effective options, whereas the Andriolo 2019 MA concludes that multiple injections are an option worth considering beyond 6 months, on trials of low methodological quality.
  • The psychosocial factors (kinesiophobia, catastrophising; Mallows 2017) must be screened for and addressed; they predict outcome as much as biomechanical factors.
  • The return to sport is based on functional criteria: quadriceps strength symmetry > 90 %, progressive pain-free plyometric tolerance, a rising VISA-P.
  • Critical differential diagnoses: patellofemoral pain syndrome, fat pad syndrome (Hoffa's disease), medial synovial plica, anteromedial meniscal lesions, Sinding-Larsen-Johansson (child), Osgood-Schlatter (adolescent), prepatellar bursitis.
  • Medication history : look for recent exposure to fluoroquinolones (ciprofloxacin, levofloxacin, ofloxacin) and to corticosteroid therapy in systemic or local form. Both increase the risk of tendinopathy and rupture, especially after the age of 60, in weight-bearing tendons and when they are combined.

Contents

  1. What are the fundamentals to know about patellar tendinopathy (jumper's knee)?
    1. How is this condition defined, who does it affect and what are the risk factors?
    2. What happens inside the tendon and how does it evolve naturally?
  2. How can patellar tendinopathy be assessed and diagnosed with certainty?
    1. Which questions should you ask to understand the patient and their history?
    2. Which clinical tests should be performed and which other conditions must be ruled out?
    3. Should patients be classified (VISA-P, clinical stages) and what are the benefits?
  3. What are the most effective treatment strategies for patellar tendinopathy?
    1. Where do you start? What is the recommended hierarchy of interventions?
    2. What is the role of exercise (PTLE, HSR, isometrics) and is one approach superior?
    3. Adjunctive therapies: what is the value of shockwave, PRP and manual therapies?
    4. Beyond the physical: how to address psychological factors?
  4. How can lasting recovery be achieved and recurrence of patellar tendinopathy prevented?
    1. How can the patient become an active participant through the pain-monitoring model?
    2. When and how should a safe return to sport be planned?
  5. Kinetic chain & vulnerable subgroup: what to do with recalcitrant tendinopathy?
    1. Ankle and hip: screening for the deficits that sustain overload
    2. Stratifying a recalcitrant tendinopathy: red flags and referral
  6. What do real clinical cases teach us about patellar tendinopathy?
    1. Analysis of a "classic" case: from assessment to resolution with PTLE.
    2. The diagnostic challenge: when anteromedial pain hides something else.
    3. A complex case study: patellar pain resolving with lumbar treatment and MDT
  7. How do you apply these recommendations concretely in your practice?
    1. When and to which other healthcare professionals should you refer?
    2. How do you measure outcomes and overcome barriers to implementation?

What are the fundamentals to know about patellar tendinopathy (jumper's knee)?

In this chapter: a contemporary definition of patellar tendinopathy (jumper's knee), updated epidemiology (Nutarelli 2023 SR/MA, Hägglund 2011, Lian 2005), risk factors ranked with training load and limited dorsiflexion at the forefront (Sprague 2018, Backman 2011), the Cook-Purdam continuum model and a natural history that is often chronic.

Patellar tendinopathy, commonly called jumper's knee or genou du sauteur (its French name), is a clinical condition of mechanical and overload origin, characterised by pain localised at the inferior pole of the patella (proximal insertion of the patellar tendon), proportional to load.¹,² Long described as "tendinitis", it is now placed in the category of non-inflammatory overload tendinopathies (“tendinoses”): histological studies of tendon biopsies find disorganisation of the collagen fibres, an increase in ground substance and neovascularisation, without a classic inflammatory infiltrate.³ This nuance shapes the therapeutic approach: one does not suppress an inflammation, one guides tendon adaptation to load. 🦵

How is this condition defined, who does it affect and what are the risk factors?

The ICON 2019 terminology consensus (Scott et al., Br J Sports Med 2020) retains the term “tendinopathy” (in English: patellar tendinopathy; in French: tendinopathie rotulienne or patellaire) rather than tendinitis or tendinosis.¹⁶ The classic site of pain is the inferior pole of the patella (proximal insertion, 95 % of cases); distal forms (insertion on the anterior tibial tuberosity) are rare in adults and more frequent in paediatrics (Osgood-Schlatter disease).¹,⁴

The prevalence is particularly high in jumping sports. The Nutarelli 2023 meta-analysis (Orthop J Sports Med, 73 studies, n > 11,000 athletes), the most recent and most comprehensive epidemiological SR/MA to date, establishes an overall prevalence of 18.3 % in athletes, compared with only 0.1 % in the general population.⁵ By sport: volleyball 24.8 %, basketball 20.8 %, football/soccer 6.1 %. Prevalence is 2× higher in adults (21.3 %) than in minors (10.1 %), and higher in men (17 %) than in women (11.2 %). The incidence per season reaches 7 % in athletes practising a jumping sport.⁵ The historical cohort of Lian 2005 (Am J Sports Med, n = 613 elite Norwegian athletes, 9 sports) already found a point prevalence of 14.2 %, reaching 44 % in volleyball and 32 % in basketball, confirming the robustness of the sport-specific gradient.⁶ In male professional footballers, the UEFA cohort of Hägglund 2011 (n = 2,229 players, 7 seasons) documented a point prevalence of 2.4 % and a higher incidence per 1,000 match hours on artificial surfaces.⁷

18.3 %Prevalence in athletes (Nutarelli 2023)
24.8 %Prevalence in volleyball (Nutarelli 2023)
×1.5Higher risk in men (17 % vs 11.2 %)
18-30 yearsAge group mainly affected

📊 Prevalence of patellar tendinopathy by sport (Nutarelli 2023, SR/MA OJSM)

Point prevalence in athletes: 73 studies, n > 11,000

Prevalence of patellar tendinopathy by sport 0 % 10 % 20 % 30 % 40 % Volleyball 24.8 % Basketball 20.8 % Athletes (overall) 18.3 % Football / soccer 6.1 % Male athletes 17 % Female athletes 11.2 % General population 0.1 %

Source: Nutarelli S, da Lodi CMT, Cook JL, Deabate L, Filardo G. Orthop J Sports Med. 2023;11(6):23259671231173659. PMID 37347023.

The risk factors are multifactorial. The Sprague 2018 systematic review (Br J Sports Med) of 31 studies (6 prospective, 25 cross-sectional) failed to identify a modifiable factor with strong evidence, but established significant associations for several modifiable variables.⁸ The synthesis of the 2018-2023 literature brings out the following factors:

  • Training load : high weekly jump volume, sudden increase in intensity, high competition frequency. This is the most consistent factor: the condition is load-induced by definition.²,⁸,⁹
  • Poor ankle dorsiflexion (< 36.5°): Backman & Danielson 2011 (Am J Sports Med, 1-year prospective cohort, 90 elite junior basketball players) showed that subjects with more limited dorsiflexion developed ~2 times more patellar tendinopathy.¹⁰ Mechanism: limited dorsiflexion is compensated by increased knee flexion and anterior tibial translation on landing.
  • Quadriceps and gluteal strength deficit: associated with poor absorption of stresses on landing and excessive loading of the tendon.⁹,¹¹
  • Landing mechanics : high peak landing force, landing in dynamic valgus, little hip flexion, poor neuromuscular control (Sprague 2018, Theodorou 2023).⁸,¹²
  • Anthropometry : high BMI, larger Q angle, particular tendon dimensions; non-modifiable factors.²
  • Male sex : OR ≈ 1.5 in adult men (Nutarelli 2023). Probably linked to jump power and cumulative overload.⁵
  • History of tendinopathy or of lower-limb pain: a very strong predictor of recurrence.⁸
  • Competition volume : Hägglund 2011, in the UEFA cohort, shows that match frequency increases the risk.⁷

⚖️ Hierarchy of modifiable risk factors (associations identified)

Synthesis of the clinical factors identified by the 2018-2023 SRs/MAs

Risk factors (OR/RR) for patellar tendinopathy OR/RR = 1 (ref) 2 3 4 5 Training load ↑ RR ≈ 3 (strong assoc.) Ankle dorsiflexion ↓ ≈ ×2 (Backman 2011) Prior tendinopathy OR ≈ 2.4 Jump volume ↑ OR ≈ 1.8 Male sex (vs F) OR 1.5 High BMI OR ≈ 1.4

Sources: Sprague 2018 (SR), Backman & Danielson 2011 (junior basketball cohort, AJSM 39(12):2626-2633), Nutarelli 2023 (sex), McAuliffe 2022 (prognosis SR).

“Patellar tendinopathy is not a fault of the tendon, it is a fault of dosage. The tendon has a capacity; beyond it, it protests. The clinical key is less to look for ‘which exercise makes the pain disappear’ than to restore an asymmetry between applied load and tissue capacity.”

What happens inside the tendon and how does it evolve naturally?

The most widely used conceptual framework remains the Cook & Purdam 2009 continuum (PMID 18812414), revisited and nuanced in 2016. It describes three states of tendon structure that can coexist, move in one direction or the other, and guide load modulation:¹³,¹⁴

  1. Reactive tendinopathy : proliferative non-inflammatory response to acute overload (sudden increase in jump volume, return to sport after a break, etc.). The tendon thickens transiently through an increase in proteoglycans to resist stress. A reversible state with a load reduction and analgesic isometrics.
  2. Tendon dysrepair (remodelling) : if overload persists, the matrix becomes disorganised, cellularity increases, angiogenic factors appear (new vessels). A partially reversible state: progressive loading (HSR, PTLE, eccentric) stimulates remodelling.
  3. Degenerative tendinopathy : areas of focal cell necrosis, severe matrix disorganisation, dense neovascularisation. Often located in the proximal portion of the patellar tendon (enthesis junction) and surrounded by still-healthy tissue. The structural changes are poorly reversible; the therapeutic goal becomes to optimise the function of the remaining healthy tissue to compensate for the degenerated area.¹⁴

🔄 The Cook-Purdam continuum: 3 states of the patellar tendon

Key model for adapting loading to the clinical stage

Cook-Purdam continuum in patellar tendinopathy 1. Reactive Acute overload (jumps ↑↑) Transient thickening No disorganisation REVERSIBLE ↓ Plyometric load + Analgesic isometrics Isometrics: brief analgesia possible 2. Dysrepair Persistent overload Matrix disorganisation Early neovascularisation PARTIALLY REVERSIBLE Progressive loading PTLE (Breda 2021) or HSR Single-leg decline squat 3. Degenerative Focal necrosis (patellar pole) Dense neovascularisation Healthy tissue at the periphery BARELY REVERSIBLE Optimise healthy tissue + unproven adjunct if refractory Risk ↑ of rupture (rare) Inappropriate mechanical load ↓ Tendon capacity ↑ progression Load reduction + progressive work ↑ Tendon capacity ↓ regression

Source: Cook JL, Purdam CR. Br J Sports Med. 2009;43(6):409-416. PMID 18812414. Revisited in Cook 2016 Br J Sports Med 50(19):1187-1191 (PMID 27127294).

The model is conceptual and educational. The three states can coexist within the same tendon (a degenerative area surrounded by reactive tissue), and they cannot be formally distinguished without biopsy. Its clinical value lies in guiding load modulation : a "reactive" tendon (a volleyball player at the start of the season with jump overload for 3 weeks) responds to an immediate load reduction and to isometric work, whereas a "degenerative" tendon (a 30-year-old basketball player with pain for 18 months and marked ultrasound findings) requires prolonged remodelling.¹⁴ The natural history of patellar tendinopathy without adequate intervention is unfavourable. The historical cohort of Kettunen 2002 (Am J Sports Med, 15-year follow-up of male athletes) documented that more than 50 % of athletes with jumper's knee had to give up their sport, and that symptoms can persist for years.¹⁵ Cook & Purdam 2009 stress that the condition rarely resolves spontaneously as long as the athlete continues to be exposed to the triggering activities.¹³ An active and progressive conservative approach, started early, is therefore the rule.

Key points

  • Patellar tendinopathy is a tendinosis (non-inflammatory overload condition), with pain localised at the inferior pole of the patella (proximal insertion of the patellar tendon).
  • Prevalence in athletes: 18.3 % (Nutarelli 2023, SR/MA OJSM). Volleyball 24.8 %, basketball 20.8 %, football 6.1 %. General population 0.1 %.
  • Preferentially affects men (17 % vs 11.2 %) and adult athletes (21.3 % vs 10.1 % in minors).
  • Key risk factors : poorly managed training load, poor ankle dorsiflexion (Backman 2011, ×2 risk), history of tendinopathy, deficient landing mechanics, reduced quadriceps/hip strength.
  • The Cook-Purdam continuum (reactive → dysrepair → degenerative) remains the reference teaching framework for guiding load modulation. The three states can coexist.
  • Unfavourable natural history without structured intervention: more than 50 % of athletes forced to give up their sport (Kettunen 2002, 15-year follow-up). A progressive conservative approach is required from the first episode.
Bibliography
  1. Malliaras P, Cook J, Purdam C, Rio E. Patellar Tendinopathy: Clinical Diagnosis, Load Management, and Advice for Challenging Case Presentations. J Orthop Sports Phys Ther. 2015;45(11):887-898. PMID 26390269.
  2. Rudavsky A, Cook J. Physiotherapy management of patellar tendinopathy (jumper's knee). J Physiother. 2014;60(3):122-129. PMID 25092419.
  3. Khan KM, Bonar F, Desmond PM, et al. Patellar tendinosis (jumper's knee): findings at histopathologic examination, US, and MR imaging. Radiology. 1996;200(3):821-827. PMID 8756939.
  4. Theodorou A, Komnos G, Hantes M. Patellar tendinopathy: an overview of prevalence, risk factors, screening, diagnosis, treatment and prevention. Arch Orthop Trauma Surg. 2023;143(11):6695-6705. PMID 37542006.
  5. Nutarelli S, da Lodi CMT, Cook JL, Deabate L, Filardo G. Epidemiology of Patellar Tendinopathy in Athletes and the General Population: A Systematic Review and Meta-analysis. Orthop J Sports Med. 2023;11(6):23259671231173659. PMID 37347023.
  6. Lian OB, Engebretsen L, Bahr R. Prevalence of jumper's knee among elite athletes from different sports: a cross-sectional study. Am J Sports Med. 2005;33(4):561-567. PMID 15722279.
  7. Hägglund M, Zwerver J, Ekstrand J. Epidemiology of patellar tendinopathy in elite male soccer players. Am J Sports Med. 2011;39(9):1906-1911. PMID 21642599.
  8. Sprague AL, Smith AH, Knox P, Pohlig RT, Grävare Silbernagel K. Modifiable risk factors for patellar tendinopathy in athletes: a systematic review and meta-analysis. Br J Sports Med. 2018;52(24):1575-1585. PMID 30054341.
  9. McAuliffe S, McCreesh K, Culloty F, Purtill H, O'Sullivan K. Can ultrasound imaging predict the development of Achilles and patellar tendinopathy? A systematic review and meta-analysis. Br J Sports Med. 2016;50(24):1516-1523. PMID 27633025.
  10. Backman LJ, Danielson P. Low range of ankle dorsiflexion predisposes for patellar tendinopathy in junior elite basketball players: a 1-year prospective study. Am J Sports Med. 2011;39(12):2626-2633. PMID 21917610.
  11. Mendonça LM, Leite HR, Zwerver J, Henschke N, Branco G, Oliveira VC. How strong is the evidence that conservative treatment reduces pain and improves function in individuals with patellar tendinopathy? A systematic review of randomised controlled trials including GRADE recommendations. Br J Sports Med. 2020;54(2):87-93. PMID 31171514.
  12. Bisseling RW, Hof AL, Bredeweg SW, Zwerver J, Mulder T. Are the take-off and landing phase dynamics of the volleyball spike jump related to patellar tendinopathy?. Br J Sports Med. 2008;42(6):483-489. PMID 18385187.
  13. Cook JL, Purdam CR. Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy. Br J Sports Med. 2009;43(6):409-416. PMID 18812414.
  14. Cook JL, Rio E, Purdam CR, Docking SI. Revisiting the continuum model of tendon pathology: what is its merit in clinical practice and research? Br J Sports Med. 2016;50(19):1187-1191. PMID 27127294.
  15. Kettunen JA, Kvist M, Alanen E, Kujala UM. Long-term prognosis for jumper's knee in male athletes. A prospective follow-up study. Am J Sports Med. 2002;30(5):689-692. PMID 12239003.
  16. Scott A, Squier K, Alfredson H, et al. ICON 2019: International Scientific Tendinopathy Symposium Consensus: Clinical Terminology. Br J Sports Med. 2020;54(5):260-262. PMID 31399426.

How can patellar tendinopathy be assessed and diagnosed with certainty?

Longitudinal ultrasound of the patellar tendon: hypoechoic area of oedema within the tendon, below the tip of the patella, indicating tendinopathy.

UltrasoundLongitudinal ultrasound of the patellar tendon: hypoechoic area of oedema within the tendon, below the tip of the patella, indicating tendinopathy.

Source : Pascual-Garrido et al., Stem Cells International, 2012, figure 2 · CC BY

In this chapter: a clinically guided approach (history + palpation + decline squat), clinical provocation tests, the place of imaging as a second-line investigation, the VISA-P score (Visentini 1998), an exhaustive differential diagnosis (patellofemoral pain syndrome, Hoffa's disease, plica, Sinding-Larsen-Johansson, Osgood-Schlatter), the Blazina clinical staging classification and therapeutic stratification.

The diagnosis of patellar tendinopathy is essentially clinical and rests on three pillars: the precise location of the pain at the tip of the patella, the dose-response relationship with energy storage and release activities, and the reproduction on the decline squat performed on one leg.¹,² The Muaidi 2023 diagnostic review (Knee Surg Sports Traumatol Arthrosc) of clinical tests for patellar tendinopathy confirms that no single test has perfect sensitivity and specificity; the diagnosis results from a cluster of clinical findings.³ Imaging is not recommended as a first-line investigation : the correlation between structural abnormalities on ultrasound/MRI and symptoms is poor; a thickened tendon with neovascularisation can be asymptomatic in a healthy jumper.⁴ Treat the patient, not the image.

Which questions should you ask to understand the patient and their history?

The history opens all the reasoning. 📝 It should characterise the pain, identify actionable risk factors and confirm the typical load-induced pattern.²,⁵

  • Precise location of the pain : ask the patient to point with one finger. Typical patellar tendinopathy is almost pinpoint at the inferior pole of the patella (95 % of cases, proximal insertion of the patellar tendon).¹ Diffuse, medial or retropatellar pain should prompt reconsideration of the diagnosis.
  • Mode of onset : insidious and progressive over several weeks, typical of an overload tendinopathy. Pain of sudden onset after a jump, with a sensation of a “pop”, should raise suspicion of an avulsion fracture of the inferior pole or a partial patellar tendon rupture : a red flag.
  • Load-pain dose-response relationship (pathognomonic): the pain appears and intensifies during jumps, landings, decelerations, sprints, going up/down stairs, deep squats. The “warm-up” pattern is common: initial pain that decreases with warming up, then reappears after exercise and the next morning.²
  • Recent changes in training load : return after a break, sudden increase in jump volume or match frequency, change of surface (wooden floor → asphalt), of footwear, of coach or of programme.⁵
  • Sporting profile : volleyball, basketball, jumping sports (gymnastics, diving, athletics: long jump, high jump, triple jump), fast running or changes of direction.⁶,⁷
  • Personal history of tendinopathy (patellar or other): the strongest risk factor for recurrence.⁹
  • Psychosocial profile : fear of movement, catastrophising, beliefs about pain (“my tendon is going to rupture, I have to stop”), level of self-efficacy; these are major predictors of chronicity (Mallows 2017).¹⁰
  • Baseline VISA-P score : 8 questions (0-100, 100 = asymptomatic), the reference PROM tool, validated internationally since Visentini 1998.¹¹ It allows severity to be quantified objectively and progress to be tracked.

🚩 Red flags to screen for from the history onwards

  • Audible “pop” after a jump + acute pain + inability to fully extend the knee actively → patellar tendon rupture or avulsion fracture of the inferior pole. Orthopaedic emergency (ultrasound or MRI).
  • Constant night pain, sweats, weight loss → reconsider the diagnosis (systemic inflammatory process, tumour) → blood tests and MRI.
  • Warm swelling, fever, redness → cellulitis, septic prepatellar bursitis, septic arthritis → emergency.
  • True joint locking, instability, giving way → meniscal lesion, ACL injury, symptomatic synovial plica → orthopaedic consultation.
  • Adolescent < 16 years with pain at the tip of the patella → suspect Sinding-Larsen-Johansson disease (fragmentation/apophysitis of the inferior pole of the patella). Lateral radiograph.
  • Adolescent with pain at the anterior tibial tuberosity → Osgood-Schlatter disease. Lateral radiograph.

Which clinical tests should be performed and which other conditions must be ruled out?

Sagittal knee MRI: area of low signal in the proximal portion of the patellar tendon, marked with an asterisk, characteristic of patellar tendinopathy.

MRISagittal knee MRI: area of low signal in the proximal portion of the patellar tendon, marked with an asterisk, characteristic of patellar tendinopathy.

Source : Pascual-Garrido et al., Stem Cells International, 2012, figure 1 · CC BY

The physical examination combines palpation, functional tests and assessment of the kinetic chain. 🩺 No single test is sensitive and specific enough to establish the diagnosis: it is their convergence that confirms it.³

Localised palpation : the most reliable and reproducible test. With the knee in full extension (quadriceps relaxed to expose the inferior pole), direct pressure on the inferior pole of the patella reproduces the familiar pain. The pain disappears when the quadriceps is contracted (the passive flexion sign of Cook). Focal thickening compared with the unaffected side is suggestive.¹

Single-leg decline squat (SLDS) : the most useful functional provocation test. Standing on a board inclined at 25° (decline), the patient performs a single-leg squat to 60° of knee flexion. Reproduction of the familiar pain at the tip of the patella strongly favours patellar tendinopathy.¹,² The specific increase in load on the patellar tendon (vs a standard squat) explains its greater sensitivity.

Kinetic chain assessment :

  • Ankle dorsiflexion range (“knee-to-wall” test): a distance < 9-10 cm is a demonstrated risk factor (Backman 2011).¹²
  • Quadriceps strength (isometric, Sorensen position or hand-held dynamometry): an asymmetry ≥ 10 % vs the unaffected side is suggestive.²
  • Hip abductor and external rotator strength : weakness associated with dynamic valgus on landing.¹³
  • Qualitative single-leg squat / drop jump : observation of dynamic knee valgus, hip flexion and neuromuscular control.²,¹³
Clinical testWhat it assessesPerformanceLevel of evidence
Palpation of the inferior pole of the patellaReproduction of localised painHigh sensitivity, moderate specificityHigh
Single-leg decline squat (SLDS)Reproduction under specific loadHighest sensitivity of the functional testsHigh
Passive flexion signDistinguishing tendinopathy from other causesHigh specificityModerate
VISA-P (PROM)Overall severity and longitudinal follow-upExcellent validity and responsiveness (MCID 13-15 pts)High
Knee-to-wall (dorsiflexion)Ankle risk factorGood reliability (Backman 2011)Moderate
Isometric quadriceps strengthFunctional indicator for RTSPredictive of return to sport (symmetry > 90 %)High
Ultrasound / MRISecond-line anatomical assessmentPoor symptom/imaging correlationLow for primary diagnosis

Place of imaging : the McAuliffe 2016 SR/MA showed that ultrasound abnormalities predict on average a modest increase in the risk of developing tendinopathy in asymptomatic athletes, but with insufficient specificity and predictive value for routine clinical use.¹⁴ Imaging is justified in 4 situations:

  1. Suspected patellar tendon rupture or avulsion fracture of the inferior pole (ultrasound or MRI).
  2. Failure of at least 12 weeks of well-conducted conservative treatment → reassess the diagnosis.
  3. Suspected alternative diagnosis (meniscal lesion, symptomatic plica, stress fracture, tumour process).
  4. Surgical request, as a preoperative assessment.

🎯 The differential diagnosis must be systematic because several conditions can mimic patellar tendinopathy:

  • Patellofemoral pain syndrome (PFPS) : diffuse retro/peripatellar pain, aggravated by prolonged sitting (the cinema sign), going up/down stairs, deep squatting. No localised pain at the tip of the patella.¹⁵
  • Infrapatellar fat pad syndrome (Hoffa's disease) : pain on either side of the patellar tendon (and not on the tendon), aggravated in hyperextension. Hoffa's test (para-tendinous pressure in extension reproduces the pain, not the squat).
  • Symptomatic medial synovial plica : anteromedial pain, clicking sensation, sometimes associated bursitis. The plica snap test. Diagnosis is often delayed in adolescent athletes.
  • Meniscal lesion (particularly of the anterior horn of the medial meniscus): pain in deep flexion, locking, positive McMurray. Beware of the reverse trap: the Petrolo 2022 case (PMC9512301) reports a 15-year-old football player labelled with a “lateral meniscal lesion” on MRI, in whom clinical examination found no meniscal signs and whose pain was due to patellar tendinopathy.¹⁶
  • Prepatellar bursitis : superficial anterior swelling (over the patella), pain on direct pressure on the bursa.
  • Sinding-Larsen-Johansson disease (child aged 10-13): pain at the inferior pole of the patella with radiological fragmentation. Apophysitis of the proximal insertion of the tendon.
  • Osgood-Schlatter disease (adolescent aged 11-15): pain at the anterior tibial tuberosity (distal insertion of the tendon). Apophysitis.
  • Quadriceps tendinopathy (above the patella): rarer, found in elite jumpers and weightlifters.
  • Medial patellofemoral ligament injury / patellar instability : episodes of dislocation/subluxation.

Should patients be classified (VISA-P, clinical stages) and what are the benefits?

Yes, classification is useful for standardising, monitoring and stratifying. Several systems coexist:

  1. VISA-P score (Victorian Institute of Sport Assessment-Patella) from Visentini 1998: the internationally recognised PROM tool.¹¹ 8 questions scored from 0 to 100: daily pain, functional capacity, sports participation. Score 100 = asymptomatic. MCID 13-15 points. Recommended for baseline measurement, follow-up and return-to-sport criteria.
  2. Blazina clinical staging classification (modified) is useful for teaching how to adapt load management:¹⁷
    • Stage 1 : pain only after activity, without functional limitation. Sport possible with adjustments.
    • Stage 2 : pain at the start of activity (warm-up), during and after, but performance preserved. Training modifications.
    • Stage 3 : pain during and after, limited performance. Significant reduction or temporary cessation of high-load activities.
    • Stage 4 : pain in activities of daily living, increased risk of rupture. Stopping sport, intensive management.
  3. Cook-Purdam continuum (reactive/dysrepair/degenerative): guides load modulation (chapter 1).¹⁵
“The trap is not missing patellar tendinopathy: pain at the tip of the patella in a jumper is obvious. The trap is missing another condition hiding behind it: a meniscal lesion in an adolescent, an avulsion fracture after a powerful jump, or Sinding-Larsen syndrome in a pre-adolescent.”

Key points

  • The diagnosis is essentially clinical. Imaging is not necessary as a first-line investigation (poor imaging-symptom correlation, McAuliffe 2016).
  • Diagnostic triad : very localised pain at the inferior pole of the patella + dose-response relationship with load (jumps, decelerations) + reproduction on the single-leg decline squat (SLDS).
  • The VISA-P score (Visentini 1998) is the reference PROM tool (0-100). MCID 13-15 points.
  • Systematic complementary assessment of the kinetic chain : ankle dorsiflexion, quadriceps and hip strength, landing mechanics.
  • Red flags to screen for: rupture/avulsion fracture (“pop” + loss of extension), infection/tumour, true joint locking.
  • Critical differential diagnoses: patellofemoral pain syndrome, Hoffa's disease, plica, meniscal lesion (but beware of false-positive MRI findings in adolescents: Petrolo 2022), Sinding-Larsen-Johansson in children, Osgood-Schlatter in adolescents.
  • Useful classifications: VISA-P (severity), Blazina stages (load modulation), Cook-Purdam continuum (tissue state).
Bibliography
  1. Malliaras P, Cook J, Purdam C, Rio E. Patellar Tendinopathy: Clinical Diagnosis, Load Management, and Advice for Challenging Case Presentations. J Orthop Sports Phys Ther. 2015;45(11):887-898. PMID 26390269.
  2. Rudavsky A, Cook J. Physiotherapy management of patellar tendinopathy (jumper's knee). J Physiother. 2014;60(3):122-129. PMID 25092419.
  3. Cook JL, Khan KM, Kiss ZS, Coleman BD, Griffiths L. Asymptomatic hypoechoic regions on patellar tendon ultrasound: A 4-year clinical and ultrasound followup of 46 tendons. Scand J Med Sci Sports. 2001;11(6):321-327. PMID 11782263.
  4. Docking SI, Cook J. How do tendons adapt? Going beyond tissue responses to understand positive adaptation and pathology development: A narrative review. J Musculoskelet Neuronal Interact. 2019;19(3):300-310. PMID 31475937.
  5. Theodorou A, Komnos G, Hantes M. Patellar tendinopathy: an overview of prevalence, risk factors, screening, diagnosis, treatment and prevention. Arch Orthop Trauma Surg. 2023;143(11):6695-6705. PMID 37542006.
  6. Nutarelli S, da Lodi CMT, Cook JL, Deabate L, Filardo G. Epidemiology of Patellar Tendinopathy in Athletes and the General Population: A Systematic Review and Meta-analysis. Orthop J Sports Med. 2023;11(6):23259671231173659. PMID 37347023.
  7. Lian OB, Engebretsen L, Bahr R. Prevalence of jumper's knee among elite athletes from different sports: a cross-sectional study. Am J Sports Med. 2005;33(4):561-567. PMID 15722279.
  8. Hägglund M, Zwerver J, Ekstrand J. Epidemiology of patellar tendinopathy in elite male soccer players. Am J Sports Med. 2011;39(9):1906-1911. PMID 21642599.
  9. Sprague AL, Smith AH, Knox P, Pohlig RT, Grävare Silbernagel K. Modifiable risk factors for patellar tendinopathy in athletes: a systematic review and meta-analysis. Br J Sports Med. 2018;52(24):1575-1585. PMID 30054341.
  10. Mallows A, Debenham J, Walker T, Littlewood C. Association of psychological variables and outcome in tendinopathy: a systematic review. Br J Sports Med. 2017;51(9):743-748. PMID 27852585.
  11. Visentini PJ, Khan KM, Cook JL, Kiss ZS, Harcourt PR, Wark JD. The VISA score: an index of severity of symptoms in patients with jumper's knee (patellar tendinosis). Victorian Institute of Sport Tendon Study Group. J Sci Med Sport. 1998;1(1):22-28. PMID 9732118.
  12. Backman LJ, Danielson P. Low range of ankle dorsiflexion predisposes for patellar tendinopathy in junior elite basketball players: a 1-year prospective study. Am J Sports Med. 2011;39(12):2626-2633. PMID 21917610.
  13. Mendonça LD, Ocarino JM, Bittencourt NFN, Macedo LG, Fonseca ST. Association of hip and foot factors with patellar tendinopathy (jumper's knee) in athletes. J Orthop Sports Phys Ther. 2018;48(9):676-684. PMID 29792104.
  14. McAuliffe S, McCreesh K, Culloty F, Purtill H, O'Sullivan K. Can ultrasound imaging predict the development of Achilles and patellar tendinopathy? A systematic review and meta-analysis. Br J Sports Med. 2016;50(24):1516-1523. PMID 27633025.
  15. Cook JL, Purdam CR. Is tendon pathology a continuum? Br J Sports Med. 2009;43(6):409-416. PMID 18812414.
  16. Petrolo A. Meniscal lesion or patellar tendinopathy? A case report of an adolescent soccer player with knee pain. J Can Chiropr Assoc. 2022;66(2):157-171. PMID 36275082.
  17. Blazina ME, Kerlan RK, Jobe FW, Carter VS, Carlson GJ. Jumper's knee. Orthop Clin North Am. 1973;4(3):665-678. PMID 4783891. [Founding article of the clinical classification].

What are the most effective treatment strategies for patellar tendinopathy?

In this chapter: the evidence-based therapeutic pyramid, the Breda 2021 PTLE programme (pivotal RCT, +28 vs +18 VISA-P points), a comparison of HSR Kongsgaard 2009 / decline eccentric / isometrics Rio 2015, shockwave therapy without demonstrated benefit when added to exercise (Challoumas 2023), the debated place of PRP (divergence between Andriolo 2019 and the Challoumas 2021 NMA), psychosocial factors (Mallows 2017) and education about tolerable pain.

The management of patellar tendinopathy has undergone a conceptual revolution over the last thirty years. The modern approach moves radically away from passive modalities (rest, NSAIDs, corticosteroids, ultrasound) in favour of an active approach centred on progressive loading, supported by patient education and pain monitoring. The Challoumas 2021 network meta-analysis (BMJ Open Sport Exerc Med, 33 RCTs covering 28 modalities) confirms the primacy of progressive loading exercise, HSR and PTLE being common frameworks, with no established superiority of one over the other, whereas PRP as monotherapy is not superior to exercise alone.¹,²

Where do you start? What is the recommended hierarchy of interventions?

The Malliaras 2015 synthesis (JOSPT) and the Theodorou 2023 overview (Arch Orthop Trauma Surg) agree: two essential pillars before any other intervention.³,⁴

  1. Patient education and load modulation : explain the non-inflammatory overload nature of the condition, deconstruct the myth of "tendinitis" requiring complete rest, present the pain-monitoring model (Silbernagel 2007), set realistic expectations (recovery = 12 weeks to 6 months, non-linear), make the patient responsible for managing their jumps and load.³,⁵
  2. Progressive exercise programme loading the quadriceps and patellar tendon: the cornerstone of treatment, recommended as first line by the 2025 Dutch guideline despite very low to low (Cochrane 2025: seven trials, 211 athletes) and very low (Dutch guideline) certainty of evidence: we start with exercise because the panel recommends it and adjuncts have not done better, not because its effect is solidly quantified. The Breda 2021 PTLE and the Kongsgaard 2009 HSR are possible frameworks.²,⁶,⁷,¹⁹,²⁰,²³

The adjunctive therapies (shockwave, manual therapies, taping) are justified only as a complement to a well-conducted exercise programme, generally after at least 12 weeks of exercise without sufficient improvement. Injections (PRP, sclerosants, corticosteroids) have not shown superiority over placebo or over exercise alone, and some are even contraindicated (corticosteroids: risk of rupture).⁸ Surgery remains exceptional, reserved for documented failures after at least 6 months of structured conservative treatment (Everhart 2017).⁹

🔺 Therapeutic pyramid for patellar tendinopathy

From the most invasive (top) to the most universal (base): hierarchy of intent

Therapeutic pyramid for patellar tendinopathy ⬆ + invasive ⬇ + universal Surgery < 5 % Exceptional recourse after failure ≥ 6 months (Everhart 2017) Injections (PRP, sclerosant, corticosteroids) ≈ 10 % PRP: divergent evidence (Andriolo 2019 vs Challoumas 2021) Shockwave + passive adjuncts ≈ 20 % ESWT: no demonstrated benefit when added to exercise Progressive exercise (PTLE / HSR / ECC) ≈ 95 % 12+ weeks; no protocol established as superior Education + load modulation 100 % Foundation: pain monitoring ≤ 5/10

⚠️ Critical reading: the percentages are expert clinical estimates illustrating the hierarchy of therapeutic intent according to the SRs/MAs (Malliaras 2015, Challoumas 2021 NMA, Theodorou 2023), not derived from an epidemiological study. The hierarchy itself is firmly established.

What is the role of exercise (PTLE, HSR, isometrics) and is one approach superior?

🏋️ Exercise is the first-line treatment, on evidence of low to very low certainty.¹⁹,²³ Three protocols structure contemporary practice, none of which is established as superior to the others:²,³,⁶

  1. Progressive Tendon-Loading Exercise (PTLE), Breda 2021 : pivotal RCT (Br J Sports Med, n=76 athletes aged 18-35 with clinically diagnosed PT confirmed on ultrasound, 24-week follow-up). A protocol in 4 progressive phases : (1) analgesic isometric → (2) isotonic with increasing load → (3) energy storage (progressive plyometric jumps) → (4) sport-specific. In this single trial, PTLE achieved a greater VISA-P improvement than decline eccentric exercise at 24 weeks (+28 versus +18 points, adjusted difference 9; 95 % CI 1 to 16); return to sport (43 % versus 27 %) did not differ significantly (p = 0.13).⁶ The Liu 2026 network meta-analysis (17 trials) finds no protocol superior to HSR at 12 weeks, without demonstrating their equivalence; only a few protocols (concentric only, flywheel, eccentric step) do worse.²¹
  2. Heavy Slow Resistance (HSR), Kongsgaard 2009 : 3 sets × 6 to 15 RM with slow movement (3 s concentric + 3 s eccentric), 3 times a week, 12 weeks. Exercises: single-leg squat on a machine or with a barbell, heavy leg press, hack squat. External load increased progressively from 15 RM (weeks 1-3) to 6 RM (weeks 9-12). The original RCT (n=39 men, 12 weeks) showed equivalence with decline eccentric exercise at 12 weeks but superiority at 6 months in patient satisfaction and collagen normalisation.⁷ Advantage: only 3 sessions/week (vs 14 with the Alfredson protocol), hence better adherence in practice.
  3. Decline eccentric (Young/Purdam protocol) : single-leg squat on a board inclined at 25° of decline (forcing knee flexion with the knee ahead of the toes), 3 × 15 repetitions, twice a day, 12 weeks, progressed with load (weighted backpack). This is the historical protocol for patellar tendinopathy (Visnes & Bahr 2007, critical SR). It has shown positive but inconsistent results as monotherapy; in the Breda 2021 trial, PTLE did better at 24 weeks.¹⁰
  4. Analgesic isometrics (Rio 2015) : isometric knee extension 5 × 45 seconds, 70 % MVIC, 1-2 times a day. The Rio 2015 crossover trial (BJSM, six in-season volleyball players) reported an immediate reduction in pain (~7.0 → 0.17 VAS) still present at 45 minutes, the last time point measured, and an increase in MVIC.¹¹ The pre-registered crossover trial by Holden 2020 (21 patients) found a reduction of about 1 point out of 10, not maintained at 45 minutes, with no advantage over dynamic exercise.²² Isometrics remain well tolerated and may relieve pain in the short term, with no duration to promise: an option for the reactive phase, the season, or as the first phase of PTLE. They do not replace a long-term progressive loading programme.

⚖️ Comparison of exercise protocols for patellar tendinopathy

Mean change in VISA-P score (original trials and NMA)

Comparison of exercise protocols for patellar tendinopathy Effect = 0 +10 +20 +30 +40 VISA-P pts PTLE (Breda 2021) +28 (at 24 wk) HSR (Kongsgaard 2009) +27 (at 6 months) Decline eccentric +18 (at 24 wk) Isometrics (short term) +9 (4 wk) Wait-and-see ~+5

Sources: Breda 2021 (pivotal RCT, n=76, BJSM, DOI 10.1136/bjsports-2020-103403), Kongsgaard 2009 (RCT, PMID 19793213), Rio 2015 (isometric crossover trial, PMID 25979840), Challoumas 2021 NMA (PMID 34900334). PTLE, HSR and loaded eccentric exercise: no demonstrated superiority between them in the 2026 NMA; concentric-only exercise is less favourable there. The bars juxtapose different trials (time horizons from 4 weeks to 6 months): they do not form a hierarchy.

Adjunctive therapies: what is the value of shockwave, PRP and manual therapies?

💡 All adjunctive modalities should be considered as a complement to an exercise programme, never as a substitute.²,³

Extracorporeal shockwave therapy (ESWT) : the Charles 2023 review (Front Immunol) finds a negligible short-term effect of ESWT, alone or added to eccentric exercise, against placebo (low to moderate evidence);¹² Challoumas 2023 finds, with moderate certainty, that adding ESWT to eccentric exercise brings no short-term benefit (two trials);²⁰ the Stania 2022 review does not allow any conclusion (extreme heterogeneity).²⁴ The 2025 Dutch guideline reserves additional treatments, shockwave included, for particular cases after 12 weeks of exercise without change, then prefers the patellar strap and asks that the patient be informed of the absence of evidence.²³ In practice, exercise continues for at least 12 weeks before any adjunct; ESWT tried afterwards is presented as a trial with no evidence of effectiveness.

PRP (Platelet-Rich Plasma) : the data are divergent, and this divergence should be explained to the patient rather than hidden. The Andriolo 2019 SR/MA (Am J Sports Med, 70 studies reviewed, 22 included in the meta-analysis) concludes that multiple injections of PRP achieve the best results beyond 6 months of follow-up (p < 0.05), ahead of shockwave and eccentric exercise, and therefore regards them as a possible option: but it does so by indirect comparison, on trials whose Coleman score indicates generally poor methodological quality.⁸ The Challoumas 2021 NMA, restricted to randomised trials, does not count PRP among the most effective interventions and concludes that progressive loading should remain the first-line treatment.² The Everhart 2017 SR finds a highly scattered improvement with PRP (55 %, 95 % CI 5 to 105 %) and suggests that it might accelerate early recovery, without settling the question.⁹ The Andia 2014 SR/MA (Br Med Bull, 13 controlled studies, various tendons) finds less pain at 3 months and at 1 year after PRP, but judges these results inapplicable to the individual patient, owing to a lack of power and precision.¹³ PRP is not recommended routinely but may be discussed after failure of at least 6 months of structured conservative treatment, as part of shared decision-making.

Intra- or peritendinous corticosteroids : strongly advised against. Documented risk of tendon rupture, high recurrence rate, structural alteration of the collagen.²,³

Manual therapy (deep transverse friction massage, ankle/hip joint mobilisations): limited evidence as monotherapy. May be justified to improve limited ankle mobility (dorsiflexion) or hip mobility (internal rotation, abductors) that maintains deficient landing mechanics, but should not form the core of treatment.² The Acebes-Hueto 2024 SR (Healthcare) on soft-tissue techniques + exercise finds a modest adjunctive effect.¹⁴

Other modalities (low-level laser, therapeutic ultrasound, electrical stimulation, taping, dry needling): insufficient or heterogeneous evidence for a strong recommendation. The 2024 Frontiers SR on dry needling + exercise finds an additional benefit, but the net effect of dry needling as monotherapy remains to be confirmed.

ModalityMain indicationLevel of evidenceExpected effect
Education + load modulationAll patientsVery low (2025 Dutch guideline)↗ adherence, ↘ recurrences, ↘ fear of movement
PTLE (Breda 2021)All patients, 24 wkLow (one trial)+28 vs +18 VISA-P pts at 24 wk (adjusted difference 9); RTS 43 % vs 27 %, NS
HSR (Kongsgaard 2009)All patients, 12 wkLow+27 VISA-P pts at 6 months, good adherence
Analgesic isometrics (Rio 2015)Reactive phase, in-seasonLowPossible short-term analgesia, duration not established
Isolated decline eccentricOff-season, motivated athletesLow+18 VISA-P pts (Breda 2021)
ESWT (chronic cases)No established indicationModerate (absence of short-term benefit)No demonstrated benefit when added to exercise (Challoumas 2023)
Manual therapy (ankle/hip)Associated mobility limitationLow to moderateAdjunct if mobility is limited
Intratendinous PRPRefractory cases > 6 monthsLow and divergent (Andriolo 2019 vs Challoumas 2021)Andriolo: multiple injections useful beyond 6 months; Challoumas: exercise as first line
Intra/peritendinous corticosteroids—Risk of rupture, recurrences ↑⚠️ To be avoided
Ultrasound / laser / TENSSymptomatic adjunctLowInsufficient evidence
Surgery (debridement, tenotomy)Failure ≥ 6 monthsExceptional recourseNo superiority vs well-conducted exercise (Everhart 2017)

Beyond the physical: how to address psychological factors?

🧠 Psychological factors are a major determinant of chronicity, and are frequently under-treated. The Mallows 2017 systematic review (BJSM) showed that kinesiophobia (fear of movement), catastrophising (negative and amplified interpretation of pain) and low self-efficacy are independent predictors of a poor prognosis at 12 months in tendinopathy in general, including patellar tendinopathy.¹⁵ Patient education must be active and proactive on four points:

  • Reframing pain : tolerable pain (≤ 5/10 VAS) during the exercises, which does not worsen during exercise and returns to baseline within 24 h, is acceptable and even productive for adapting the tendon (Silbernagel 2007 model).¹⁶
  • Deconstructing myths : “the tendon is not going to rupture because I do heavy squats”, “complete rest makes things worse rather than healing them”, “abnormal imaging does not imply severe, lasting pain”.
  • Setting realistic expectations : recovery = 3 to 6 months for a first episode, 6 to 12 months in chronic cases, non-linear, with expected fluctuations. This information prevents discouragement when a bad day comes after a week of improvement.
  • Self-efficacy : give the patient concrete tools (logbook, daily VAS, simple criteria for adjusting jump load) so that they become an active agent in their own recovery rather than a passive recipient.¹⁷

For patients with high kinesiophobia, catastrophising and established chronicity, a cognitive-behavioural approach or referral to a psychologist specialising in chronic pain may be needed in addition.


Critique and controversy

The exercise protocol war is evolving: although decline eccentric exercise was long regarded as the reference, the Breda 2021 RCT and the Challoumas 2021 NMA have called this supremacy into question. The Breda PTLE, incorporating the 4 progressive phases (isometric → isotonic → plyometric → sport-specific), did better than isolated decline eccentric exercise in one trial; the 2026 NMA shows no protocol to be superior to HSR.²,⁶,²¹ Kongsgaard's HSR remains an excellent adherence/effect compromise, particularly useful in patients for whom adherence is an issue.⁷

More problematic: the injection industry (PRP, sclerosants, stem cells, polidocanol) continues to grow even though the evidence supporting it remains of low methodological quality and divergent.²,⁸ Clinicians must take care not to give in to commercial pressure or to patients' expectations of non-validated “modern treatments”. Finally, the imaging-pain paradox remains a major clinical trap: tendons that look “healed” on ultrasound can remain painful, and vice versa.¹⁸ Return-to-sport decisions should not be based on follow-up imaging, but on functional criteria and the VISA-P (chapter 4).

Key points

  • ✅ First line: education + load modulation + a progressive exercise programme over 12+ weeks, recommended despite low to very low certainty.
  • ✅ PTLE (Breda 2021) in 4 phases : better than decline eccentric exercise at 24 weeks in one trial (+28 vs +18 VISA-P pts; return to sport 43 % vs 27 %, not significant); no protocol is established as superior to HSR.
  • ✅ HSR (Kongsgaard 2009) is an excellent alternative: 3 sessions/week, good adherence, no demonstrated difference from PTLE; the 2025 Dutch guideline prefers it.
  • ✅ Isometrics : possible short-term analgesia, for an unestablished duration (Rio 2015, Holden 2020); an option for the reactive phase and the season.
  • ✅ Shockwave therapy (ESWT) : no demonstrated benefit when added to exercise (Challoumas 2023); when tried after 12 weeks of exercise, it is presented as a trial with no evidence of effectiveness.
  • ❌ PRP: not routinely. The evidence diverges: Andriolo 2019 (MA) judges multiple injections worth considering beyond 6 months, on low-quality trials; Challoumas 2021 (NMA) keeps progressive exercise as first line.
  • ❌ Intra/peritendinous corticosteroids contraindicated (risk of rupture, recurrences).
  • ✅ Systematically address psychosocial factors : kinesiophobia and catastrophising are major predictors of failure (Mallows 2017). Pain-monitoring model ≤ 5/10.
Bibliography
  1. Theodorou A, Komnos G, Hantes M. Patellar tendinopathy: an overview of prevalence, risk factors, screening, diagnosis, treatment and prevention. Arch Orthop Trauma Surg. 2023;143(11):6695-6705. PMID 37542006.
  2. Challoumas D, Pedret C, Biddle M, et al. Management of patellar tendinopathy: a systematic review and network meta-analysis of randomised studies. BMJ Open Sport Exerc Med. 2021;7(4):e001110. PMID 34900334.
  3. Malliaras P, Cook J, Purdam C, Rio E. Patellar Tendinopathy: Clinical Diagnosis, Load Management, and Advice for Challenging Case Presentations. J Orthop Sports Phys Ther. 2015;45(11):887-898. PMID 26390269.
  4. Rudavsky A, Cook J. Physiotherapy management of patellar tendinopathy (jumper's knee). J Physiother. 2014;60(3):122-129. PMID 25092419.
  5. Cook JL, Purdam CR. Is tendon pathology a continuum? Br J Sports Med. 2009;43(6):409-416. PMID 18812414.
  6. Breda SJ, Oei EHG, Zwerver J, Visser E, Waarsing E, Krestin GP, de Vos RJ. Effectiveness of progressive tendon-loading exercise therapy in patients with patellar tendinopathy: a randomised clinical trial. Br J Sports Med. 2021;55(9):501-509. DOI 10.1136/bjsports-2020-103403.
  7. Kongsgaard M, Kovanen V, Aagaard P, et al. Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy. Scand J Med Sci Sports. 2009;19(6):790-802. PMID 19793213.
  8. Andriolo L, Altamura SA, Reale D, Candrian C, Zaffagnini S, Filardo G. Nonsurgical Treatments of Patellar Tendinopathy: Multiple Injections of Platelet-Rich Plasma Are a Suitable Option: A Systematic Review and Meta-analysis. Am J Sports Med. 2019;47(4):1001-1018. PMID 29601207.
  9. Everhart JS, Cole D, Sojka JH, et al. Treatment Options for Patellar Tendinopathy: A Systematic Review. Arthroscopy. 2017;33(4):861-872. PMID 28110807.
  10. Visnes H, Bahr R. The evolution of eccentric training as treatment for patellar tendinopathy (jumper's knee): a critical review of exercise programmes. Br J Sports Med. 2007;41(4):217-223. PMID 17261559.
  11. Rio E, Kidgell D, Purdam C, et al. Isometric exercise induces analgesia and reduces inhibition in patellar tendinopathy. Br J Sports Med. 2015;49(19):1277-1283. PMID 25979840.
  12. Charles R, Fang L, Zhu R, Wang J. The effectiveness of shockwave therapy on patellar tendinopathy, Achilles tendinopathy, and plantar fasciitis: a systematic review and meta-analysis. Front Immunol. 2023;14:1193835. PMID 37662911.
  13. Andia I, Latorre PM, Gomez MC, et al. Platelet-rich plasma in the conservative treatment of painful tendinopathy: a systematic review and meta-analysis of controlled studies. Br Med Bull. 2014;110(1):99-115. PMID 24795364.
  14. Ragone F, Pérez-Guillén S, Carrasco-Uribarren A, et al. The Effects of Soft-Tissue Techniques and Exercise in the Treatment of Patellar Tendinopathy-Systematic Review and Meta-Analysis. Healthcare (Basel). 2024;12(4):427. PMID 38391804.
  15. Mallows A, Debenham J, Walker T, Littlewood C. Association of psychological variables and outcome in tendinopathy: a systematic review. Br J Sports Med. 2017;51(9):743-748. PMID 27852585.
  16. Silbernagel KG, Thomeé R, Eriksson BI, Karlsson J. Continued sports activity, using a pain-monitoring model, during rehabilitation in patients with Achilles tendinopathy: a randomized controlled study. Am J Sports Med. 2007;35(6):897-906. PMID 17307888.
  17. Chimenti RL, Frey-Law LA, Sluka KA. A Mechanism-Based Approach to Physical Therapist Management of Pain. Phys Ther. 2018;98(5):302-314. PMID 29669091.
  18. Docking SI, Cook J. Pathological tendons maintain sufficient aligned fibrillar structure on ultrasound tissue characterization (UTC). Scand J Med Sci Sports. 2016;26(6):675-683. PMID 26059532.
  19. Lopes AD, Rizzo RR, Hespanhol L, Costa LO, Kamper SJ. Exercise for patellar tendinopathy. Cochrane Database Syst Rev. 2025;5(5):CD013078. PMID 40421598.
  20. Challoumas D, Crosbie G, O'Neill S, Pedret C, Millar NL. Effectiveness of Exercise Treatments with or without Adjuncts for Common Lower Limb Tendinopathies: A Living Systematic Review and Network Meta-analysis. Sports Med Open. 2023;9(1):71. PMID 37553459.
  21. Liu Y, Li C, Yang F. Comparative effectiveness of exercise interventions for patellar tendinopathy: a systematic review and network meta-analysis of randomized controlled trials. BMC Sports Sci Med Rehabil. 2026;18(1):296. PMID 42192475.
  22. Holden S, Lyng K, Graven-Nielsen T, et al. Isometric exercise and pain in patellar tendinopathy: A randomized crossover trial. J Sci Med Sport. 2020;23(3):208-214. PMID 31735531.
  23. Ophey M, Koëter S, van Ooijen L, et al. Dutch multidisciplinary guideline on anterior knee pain: Patellofemoral pain and patellar tendinopathy. Knee Surg Sports Traumatol Arthrosc. 2025;33(2):457-469. PMID 39045713.
  24. Stania M, Król T, Marszałek W, Michalska J, Król P. Treatment of Jumper's Knee with Extracorporeal Shockwave Therapy: A Systematic Review and Meta-Analysis. J Hum Kinet. 2022;84:124-134. PMID 36457482.

How can lasting recovery be achieved and recurrence of patellar tendinopathy prevented?

In this chapter: the pain-monitoring model (Silbernagel 2007), a structured 4-phase RTS programme (Breda 2021 PTLE), objective functional criteria (pain-free single-leg decline squat, quadriceps strength symmetry > 90 %, plyometric tolerance), long-term prevention of recurrence and the trajectory of the jumping athlete.

The lasting recovery and the prevention of recurrence are the major challenge in patellar tendinopathy: the historical Kettunen 2002 cohort (Am J Sports Med, 15-year follow-up) documented that more than 50 % of athletes had to give up their sport because of persistent symptoms.¹ Beyond resolving the acute episode, the patient must be prepared for a structured return to jumping activities, and for years of self-monitoring of sporting load.

How can the patient become an active participant through the pain-monitoring model?

🎯 The Silbernagel 2007 pain-monitoring model transformed management by demonstrating, in a randomised trial (n = 38), that continuing sport during rehabilitation is not only safe but also effective, provided a simple rule is followed:²

  • Pain kept tolerable (≤ 5/10 VAS) during exercise.
  • Pain that does not worsen from session to session.
  • Pain that returns to baseline within 24 h after exercise.
  • Morning stiffness that does not worsen from week to week.

If any of these criteria is not met → reduce the load (speed, distance, intensity, frequency) by 20-30 % and reassess. If the criteria are met → increase progressively (the +10 %/week rule is a benchmark, with no demonstrated predictive value).

🚦 Silbernagel pain-monitoring model

A simple rule for allowing, adjusting or stopping activity

Silbernagel pain-monitoring model ✓ GREEN ZONE Pain ≤ 5/10 VAS No worsening Back to baseline in 24 h Stable morning stiffness → Continue +10 %/week (benchmark) Productive loading ⚠ AMBER ZONE Pain 5-7/10 VAS Modest worsening Back to baseline > 24 h Morning stiffness ↗ → Reduce load -(20-30) % Reassess at 7 days ⛔ RED ZONE Pain ≥ 7/10 VAS Marked worsening Persists > 48 h Wakes at night → Stop activity Reassess dx Look for red flags

Adapted from Silbernagel KG et al. Am J Sports Med. 2007;35(6):897-906 (PMID 17307888) and from the 2015 JOSPT RTS programme.

Concrete tools to give the patient:

  • Logbook kept weekly: jump volume (number, intensity), morning and post-exercise pain VAS, morning stiffness. It makes trends objective and allows decisions to be taken without emotional bias.³
  • Monthly VISA-P : 0-100 score to objectify progress. An improvement of 13-15 points is clinically significant (MCID).⁴
  • Maintaining the strengthening programme in the long term: at least 2-3 sessions of HSR or loaded squats per week, even after complete resolution of symptoms, to maintain tendon capacity.⁵
  • Regulating external load : progression of jump volume adjusted to the tendon's response the next day, a season plan including 1 deload week every 3-4 weeks. The 10 % per week rule and the acute:chronic workload ratio are benchmarks drawn from team sports, contested and not validated as prevention tools.⁶ ¹² ¹³

When and how should a safe return to sport be planned?

🏃 Return to sport (RTS) should never be based on elapsed time alone or on the absence of pain. The Breda 2021 PTLE protocol now structures RTS into 4 progressive phases with objective functional criteria.⁷

Minimum criteria to meet before resuming jumping / sport-specific activity :

  1. No pain on the single-leg decline squat (SLDS) repeated 5 times consecutively.
  2. Quadriceps strength symmetry ≥ 90 % vs the unaffected side (hand-held dynamometry or isokinetic measurement).⁸
  3. Hop tests (single-leg hop, triple hop, side hop) with asymmetry < 10 % vs the unaffected side.
  4. VISA-P > 80/100 or a clinically significant improvement ≥ 15 points from baseline.
  5. Tolerance of bilateral then unilateral jumping, drop-jump landing with good neuromuscular control (no dynamic valgus).
  6. Hip abductor and external rotator strength that is symmetrical, an often-neglected point (Mendonça 2018).⁹

Progression of return to sport in 4 phases (Breda PTLE) :

  1. Phase 1: pain management (weeks 0-4): analgesic isometrics (Rio 2015), modulation of sporting load, education about tolerable pain. No jumping. Low-impact activities may continue if tolerated (cycling, swimming, pull-ups).
  2. Phase 2: slow isotonic strength (weeks 4-12): HSR or slow squats with progressive load, 3 sessions/week. Concurrent work on the kinetic chain (ankle, hip). No plyometrics.
  3. Phase 3: energy storage (progressive plyometrics) (weeks 8-16): graded introduction of jumps (bilateral static → bilateral dynamic → unilateral static → unilateral dynamic). Monitor pain at 24 h.
  4. Phase 4: sport-specific (weeks 12-24): reintegration of specific movements (spike, dunk, running, decelerations, changes of direction), progressive increase in competition volume, maintenance of the strengthening programme.
“Return to sport is not granted by a calendar: it is earned through functional criteria. A VISA-P of 90/100, quadriceps strength symmetry > 90 % and a drop jump without valgus speak louder than ‘3 months without pain’.”

Realistic trajectory to share with the patient : clinically perceptible improvement expected at 4-8 weeks, peak improvement around 12-24 weeks, full recovery and return to competitive sport between 3 and 6 months for a first episode, 6 to 12 months in chronic cases (Breda 2021).⁷ More than 50 % of athletes saw their careers cut short in the historical Kettunen 2002 cohort, hence the importance of maintaining the programme and monitoring load in the long term.¹


Critique and controversy

The “5/10 VAS” threshold of the Silbernagel model is a clinical heuristic that is widely adopted, but its exact threshold has never been formally validated on a large scale in patellar tendinopathy (the original Silbernagel 2007 trial concerned the Achilles tendon). It may be too permissive for some patients (catastrophisers, kinesiophobic patients) and too restrictive for others (high-level athletes used to tolerating pain). Personalisation remains necessary according to psychological profile and activity level. The return-to-sport criteria (symmetry ≥ 90 %, VISA-P > 80) are logical, but their predictive value for non-recurrence in the long term remains only moderately established. Most studies measure the rate of return to sport, not the recurrence rate at 2-3 years in patellar tendinopathy. Finally, in routine practice, these criteria require time, equipment (hand-held dynamometer, inclined board) and specific training: the risk is that they remain theoretical and that the clinician allows return to sport on looser criteria (absence of pain at rest), which is very insufficient and increases the risk of recurrence.

Key points

  • The Silbernagel 2007 pain-monitoring model (transposed to PT) is the pivotal tool of self-management: pain ≤ 5/10 VAS, no worsening, return to baseline within 24 h → green zone, continue.
  • Concrete tools for the patient: jump logbook, monthly VISA-P, long-term maintenance of the HSR/PTLE programme.
  • The return to sport must be based on objective functional criteria : no pain on the SLDS, quadriceps strength symmetry > 90 %, hop tests < 10 % asymmetry, VISA-P > 80, neuromuscular control on the drop jump.
  • Programming in 4 progressive phases (Breda PTLE) over 12-24 weeks: pain management → isotonic strength → plyometrics → sport-specific.
  • Realistic trajectory: perceived improvement at 4-8 weeks, peak at 12-24 weeks, return to competition between 3 and 12 months depending on the profile. More than 50 % of athletes had to give up their sport without structured intervention (Kettunen 2002): maintaining the programme is essential.
Bibliography
  1. Kettunen JA, Kvist M, Alanen E, Kujala UM. Long-term prognosis for jumper's knee in male athletes. A prospective follow-up study. Am J Sports Med. 2002;30(5):689-692. PMID 12239003.
  2. Silbernagel KG, Thomeé R, Eriksson BI, Karlsson J. Continued sports activity, using a pain-monitoring model, during rehabilitation in patients with Achilles tendinopathy: a randomized controlled study. Am J Sports Med. 2007;35(6):897-906. PMID 17307888.
  3. Malliaras P, Cook J, Purdam C, Rio E. Patellar Tendinopathy: Clinical Diagnosis, Load Management, and Advice for Challenging Case Presentations. J Orthop Sports Phys Ther. 2015;45(11):887-898. PMID 26390269.
  4. Visentini PJ, Khan KM, Cook JL, et al. The VISA score: an index of severity of symptoms in patients with jumper's knee (patellar tendinosis). J Sci Med Sport. 1998;1(1):22-28. PMID 9732118.
  5. Kongsgaard M, Kovanen V, Aagaard P, et al. Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy. Scand J Med Sci Sports. 2009;19(6):790-802. PMID 19793213.
  6. Gabbett TJ. The training-injury prevention paradox: should athletes be training smarter and harder? Br J Sports Med. 2016;50(5):273-280. PMID 26758673.
  7. Breda SJ, Oei EHG, Zwerver J, Visser E, Waarsing E, Krestin GP, de Vos RJ. Effectiveness of progressive tendon-loading exercise therapy in patients with patellar tendinopathy: a randomised clinical trial. Br J Sports Med. 2021;55(9):501-509. DOI 10.1136/bjsports-2020-103403.
  8. Rio E, Kidgell D, Purdam C, et al. Isometric exercise induces analgesia and reduces inhibition in patellar tendinopathy. Br J Sports Med. 2015;49(19):1277-1283. PMID 25979840.
  9. Mendonça LD, Ocarino JM, Bittencourt NFN, Macedo LG, Fonseca ST. Association of hip and foot factors with patellar tendinopathy (jumper's knee) in athletes. J Orthop Sports Phys Ther. 2018;48(9):676-684. PMID 29792104.
  10. Mallows A, Debenham J, Walker T, Littlewood C. Association of psychological variables and outcome in tendinopathy: a systematic review. Br J Sports Med. 2017;51(9):743-748. PMID 27852585.
  11. Rudavsky A, Cook J. Physiotherapy management of patellar tendinopathy (jumper's knee). J Physiother. 2014;60(3):122-129. PMID 25092419.
  12. Impellizzeri FM, Woodcock S, Coutts AJ, Fanchini M, McCall A, Vigotsky AD. What Role Do Chronic Workloads Play in the Acute to Chronic Workload Ratio? Time to Dismiss ACWR and Its Underlying Theory. Sports Med. 2021;51(3):581-592. PMID 33332011.
  13. Ding L, Weldon A, Xu J, et al. Acute:chronic workload ratio and load management for team sports: a multilevel meta-analysis. Front Public Health. 2026;14:1896651. PMID 42662491.

Kinetic chain & vulnerable subgroup: what to do with recalcitrant tendinopathy?

In this chapter: systematic assessment of the kinetic chain (ankle, hip, landing mechanics) that sustains overload of the patellar tendon, identification of modifiable deficits, high-risk subgroups (jumping athletes, junior basketball players), specific red flags and a decision tree for managing recalcitrant cases.

Patellar tendinopathy that is recalcitrant (not responding to 12 weeks of well-conducted progressive exercise) calls for the framework to be reconsidered: tendon pain is rarely an isolated problem. The kinetic chain of the lower limb works as a coupled ankle-knee-hip system, in which a distal or proximal limitation imposes mechanical overload on the patellar tendon.¹,² The Mendonça 2018 cross-sectional study (J Orthop Sports Phys Ther, 192 volleyball and basketball players) shows that a combination of hip and foot factors (passive hip internal rotation, shank-forefoot alignment, hip external rotator and abductor strength) distinguishes athletes with and without patellar tendinopathy.²

Ankle and hip: screening for the deficits that sustain overload

🔄 Three areas should be systematically assessed in the jumping athlete with patellar tendinopathy:

1. Ankle dorsiflexion (knee-to-wall) : Backman & Danielson 2011 (Am J Sports Med, 1-year prospective cohort, 90 elite junior basketball players) demonstrated that athletes with limited dorsiflexion range (< 36.5°) developed ~2× more patellar tendinopathy over the season.³ Mechanism: reduced dorsiflexion is compensated by increased anterior tibial translation and knee flexion on landing, increasing the knee extensor moment and therefore the load on the patellar tendon. Clinical test: knee-to-wall (KTW); target > 10 cm bilaterally or symmetry < 1 cm. Treatment: talocrural mobilisations, specific stretching of the triceps surae (gastrocnemius + soleus), self-mobilisation at home.

2. Strength and activation of the hip stabilisers : abductors (gluteus medius), external rotators (piriformis, gemelli). A documented weakness is associated with dynamic knee valgus on landing and with mechanical overload of the patellar tendon.²,⁴ Tests: single-leg squat (observation of valgus), Trendelenburg, hand-held dynamometry of hip abduction. If the deficit is ≥ 15 % vs the unaffected side → targeted strengthening (clamshells, single-leg deadlift, hip thrust, side plank with abduction).

3. Landing mechanics (drop jump) : Bisseling 2008 (Br J Sports Med) showed in a cohort of 24 volleyball players that patients with patellar tendinopathy have a “stiffer” landing strategy : higher peak landing force, less hip flexion, “stiff-legged” landing.⁵ Rehabilitation: drop jumps with qualitative coaching (“land softly, bend hip + knee + ankle at the same time”), work on shock-absorbing reflexes, video feedback.

🔗 Decision tree: recalcitrant patellar tendinopathy

After failure of 12 weeks of well-conducted progressive exercise (PTLE / HSR)

Decision tree for recalcitrant patellar tendinopathy Failure after 12 wk of PTLE / HSR VISA-P stagnant or decreasing 1. Reconfirm the diagnosis + red flags 2. Assess the kinetic chain: ankle + hip + landing Deficit identified → Targeted programme ankle / hip + continue PTLE Reassess at 6 wk Psychosocial factors → Pain education + CBT / kinesiophobia + referral to a psychologist specialising in pain Failure ≥ 6 months in total → Unproven adjunct, decided jointly → Surgical opinion Further imaging (MRI if not done)

Adapted from Malliaras 2015 (JOSPT, PMID 26390269), Mendonça 2018 (kinetic chain, PMID 29792104), Theodorou 2023 (overview, PMID 37542006).

Stratifying a recalcitrant tendinopathy: red flags and referral

🚩 Before concluding that a tendinopathy is “recalcitrant”, it is essential to systematically reconsider the diagnosis and rule out:

  • Subclinical avulsion fracture of the inferior pole of the patella : especially if onset followed a powerful jump. Lateral radiograph + ultrasound.
  • Meniscal or plica lesion : especially in adolescents or if there is joint locking. MRI if suspected, bearing in mind that up to 63 % of asymptomatic knees in adolescent footballers show a meniscal tear on MRI (Petrolo 2022).
  • Inflammatory disease : spondyloarthritis (chronic enthesitis), early rheumatoid arthritis. If there is night pain, morning stiffness > 1 h or involvement of other entheses: blood tests (FBC, CRP, HLA-B27, RF, anti-CCP).
  • Poorly controlled diabetes : a factor of poor response to exercise, possibly through altered collagen quality.

🚩 Red flags specific to recalcitrant cases

  • Night pain, prolonged morning stiffness > 1 h, involvement of other entheses → rheumatological work-up.
  • Localised inflammatory swelling, fever, weight loss → urgent specialist referral.
  • Joint locking, giving way, intra-articular swelling → MRI (meniscal lesion, plica, chondral lesion).
  • Sudden worsening after a powerful jump with quadriceps weakness → suspected partial patellar tendon rupture, urgent ultrasound or MRI.
  • Vulnerable subgroups to screen for: adolescents in a growth spurt (Sinding-Larsen-Johansson, Osgood-Schlatter), athletes with multiple previous tendinopathies (a possible predisposition to explore), women with amenorrhoea + restrictive eating (REDs / female athlete triad).
“A tendon never suffers alone. Before declaring a patellar tendinopathy ‘recalcitrant’, check the ankle, the hip, the landing, fear of movement, diabetes. The tendon only reveals the weaknesses of the system.”

⭐ Key points

  • Patellar tendinopathy that is recalcitrant (failure ≥ 12 wk) calls for reconsidering the diagnosis and systematically assessing the kinetic chain.
  • Ankle dorsiflexion < 36.5° doubles the risk (Backman 2011): measure with the knee-to-wall test and treat with mobilisations + gastrocnemius/soleus stretching.
  • Weakness of the hip abductors/external rotators : associated with patellar tendinopathy in athletes, together with hip internal rotation and foot alignment (Mendonça 2018); to be screened for and strengthened.
  • Landing mechanics that are deficient (“stiff-legged” landing): retraining with drop jumps and coaching, video feedback.
  • After a complete review, if failure persists at 6 months: discuss ESWT as an adjunct, or even a specialist surgical opinion. Further imaging (MRI) if not done.
  • Red flags: night pain / systemic inflammation → rheumatological work-up. Locking / instability → MRI. Sudden weakness after a jump → suspected rupture.
Bibliography
  1. Malliaras P, Cook J, Purdam C, Rio E. Patellar Tendinopathy: Clinical Diagnosis, Load Management, and Advice for Challenging Case Presentations. J Orthop Sports Phys Ther. 2015;45(11):887-898. PMID 26390269.
  2. Mendonça LD, Ocarino JM, Bittencourt NFN, Macedo LG, Fonseca ST. Association of hip and foot factors with patellar tendinopathy (jumper's knee) in athletes. J Orthop Sports Phys Ther. 2018;48(9):676-684. PMID 29792104.
  3. Backman LJ, Danielson P. Low range of ankle dorsiflexion predisposes for patellar tendinopathy in junior elite basketball players: a 1-year prospective study. Am J Sports Med. 2011;39(12):2626-2633. PMID 21917610.
  4. Sprague AL, Smith AH, Knox P, et al. Modifiable risk factors for patellar tendinopathy in athletes: a systematic review and meta-analysis. Br J Sports Med. 2018;52(24):1575-1585. PMID 30054341.
  5. Bisseling RW, Hof AL, Bredeweg SW, Zwerver J, Mulder T. Are the take-off and landing phase dynamics of the volleyball spike jump related to patellar tendinopathy?. Br J Sports Med. 2008;42(6):483-489. PMID 18385187.
  6. Theodorou A, Komnos G, Hantes M. Patellar tendinopathy: an overview of prevalence, risk factors, screening, diagnosis, treatment and prevention. Arch Orthop Trauma Surg. 2023;143(11):6695-6705. PMID 37542006.

What do real clinical cases teach us about patellar tendinopathy?

In this chapter: the real Petrolo 2022 case (PMC9512301) illustrating diagnostic error in an adolescent footballer (patellar tendinopathy mistaken for a meniscal lesion on MRI), the Serres 2025 case (PMC12129631) of a marathon runner's patellar pain resolving with repeated lumbar exercises (Mechanical Diagnosis and Therapy), critical differential diagnoses, and the GRADE pyramid of evidence.

Patellar tendinopathy illustrates the permanent tension between aggregated evidence (NMA, SR/MA) and heterogeneous clinical reality. Clinical cases shed valuable light on atypical presentations, on treatment failures and on differential diagnoses of critical importance that randomised trials do not capture. 🧐 Clinicians must nevertheless interpret these cases rigorously: they illustrate but do not demonstrate efficacy.

A "classic" case: adolescent footballer, the diagnostic error reported by Petrolo 2022

The case reported by Petrolo A. 2022 (J Can Chiropr Assoc, PMID 36275082) illustrates a common diagnostic error.¹ A 15-year-old adolescent football player consults for anterior left knee pain that has been developing for 10 weeks. His general practitioner requests an MRI, which shows a lesion of the left lateral meniscus : the diagnosis of a meniscal lesion is accepted and a surgical opinion is scheduled. The patient seeks a second opinion before this consultation. The second-opinion examination found:

  • No clinical signs of meniscal involvement : it was this finding that led to the case being reopened.
  • An anterior knee pain compatible with involvement of the patellar tendon.
  • A history and an injury mechanism that did not fit with a meniscal tear.

The diagnosis retained was left patellar tendinopathy, and progressive rehabilitation was proposed rather than surgery. After a complete rehabilitation programme of 6 weeks, the patient had fully recovered.¹

⚠️ Methodological limitations: this is a single case (n = 1), level of evidence 5 (Oxford CEBM). It illustrates a clinical reasoning process, but does not demonstrate a general rule.

Major clinical lesson : in adolescent athletes, a meniscal abnormality seen on MRI is not enough to explain anterior knee pain. The author points out that up to 63 % of asymptomatic knees of adolescent footballers show a horizontal or oblique meniscal tear on MRI: the image must be compared with the history, the injury mechanism and the physical examination before making a diagnosis and, a fortiori, before indicating surgery. The corollary also applies the other way round: in the absence of a response after 6-8 weeks of well-conducted progressive exercise, systematically reconsider the diagnosis and explore intra-articular pathology (meniscal and chondral lesions, plica, ACL injury).

🧩 Petrolo 2022 case: the correct diagnostic path

15-year-old adolescent footballer, MRI “meniscal lesion” with no clinical correlate

Petrolo 2022 case: diagnostic error, patellar tendinopathy vs meniscal lesion Initial diagnosis Lateral meniscal lesion MRI, surgical opinion Reconsideration Second clinical opinion No meniscal signs Correct diagnosis Patellar tendinopathy (clinical examination) Appropriate treatment: progressive rehabilitation Full recovery at 6 wk · no surgery Level of evidence: 5 (case report) Reference: Petrolo A. J Can Chiropr Assoc 2022;66(2):157-171 (PMID 36275082)

Source: Petrolo A. J Can Chiropr Assoc. 2022;66(2):157-171. PMID 36275082. Case report: it illustrates, it does not demonstrate.

The diagnostic challenge: when anteromedial knee pain hides something else

Anteromedial knee pain in a jumping athlete is not always patellar tendinopathy. ⚠️ Several conditions can mimic this diagnosis, sometimes with serious consequences if the diagnosis is delayed:

  • 🔍 Anterior meniscal lesion (anterior horn of the medial meniscus): pain in deep flexion, positive McMurray, occasional locking. MRI for confirmation, but Petrolo 2022 points out that up to 63 % of asymptomatic knees of adolescent footballers show a meniscal tear on MRI.¹
  • 🔍 Patellofemoral pain syndrome (PFPS) : diffuse retro/peripatellar pain, aggravated by prolonged sitting (cinema sign). Compression-extension test. No localised pain at the tip of the patella.²
  • 🔍 Symptomatic medial synovial plica : anteromedial pain, clicking sensation in flexion-extension. Positive plica snap test. Diagnosis often delayed.
  • 🔍 Fat pad syndrome (Hoffa's disease) : pain on either side of the patellar tendon, aggravated in hyperextension. Hoffa's test: para-tendinous pressure in extension reproduces the pain, the squat less so.
  • 🔍 Sinding-Larsen-Johansson disease in children aged 10-13: pain at the inferior pole of the patella with radiological fragmentation. Apophysitis of the proximal insertion of the tendon.
  • 🔍 Osgood-Schlatter disease in adolescents aged 11-15: pain over the anterior tibial tuberosity (distal insertion): a different patient profile and location.
  • 🔍 Avulsion fracture of the inferior pole of the patella : after a powerful jump with a “pop” and weakness of extension. X-ray + ultrasound.
  • 🔍 Partial ACL injury or micro-instability: especially in young women, jumping athletes, abrupt decelerations. Lachman and pivot shift tests.
  • 🔍 Prepatellar bursitis : superficial anterior swelling (over the patella), distinguished by its location.

Study of a complex case: patellar pain resolving with lumbar treatment (Serres 2025)

The Serres and Van Cant 2025 case (Int J Sports Phys Ther, PMC12129631) illustrates the complexity of the extended kinetic chain.³ A 45-year-old man, a fire safety officer and volunteer firefighter, was referred by his sports physician for patellar tendinopathy of the right knee. He was preparing for a marathon, running 60 km a week, and described pain at the inferior pole of the patella, with recurrent episodes of anterior knee pain for about ten years and a current episode lasting one year. He had received no treatment for this knee. Knee MRI and arthrography were unremarkable; lumbar MRI showed L5-S1 disc disease. The initial VISA-P was 57/100, the NRS 4/10 at rest after sport and 7/10 during activity. The examination reproduced the knee pain on the single-leg decline squat, on three single-leg hops and five step-downs, whereas resisted knee extension remained pain-free with full range. As the patient reported a history of low back pain, a full lumbar examination was carried out: minimal loss of flexion and extension, low back pain on overpressure in flexion, right straight leg raise reproducing the low back pain at 60°. Assessment using Mechanical Diagnosis and Therapy (MDT, McKenzie method) showed that repeated lumbar extensions in prone lying immediately improved the decline squat, single-leg hops and step-down, whereas repeated flexions brought all signs back to their baseline state. The presentation was classified as a lumbar derangement with a directional preference for extension. The treatment consisted solely of repeated lumbar movements:

  • Repeated lumbar extension in prone lying (McKenzie protocol): 10 repetitions, 4 to 5 times a day, and before runs.
  • Progression of forces over the sessions: self-overpressure at end of range, then overpressure applied by the clinician, reproduced at home with a towel.
  • Postural correction: maintaining lumbar lordosis when sitting.

At the fourth session, about three weeks after the initial assessment, the patient reported no pain at all over the previous seven days, in long runs as in interval sessions; knee and spine tests were pain-free and the VISA-P reached 99/100, the NRS 0/10 at rest after sport and during activity. He completed his marathon without knee pain. At six months he was running without pain, continuing his lumbar extensions, and reported a VISA-P of 100/100. His Achilles tendon pain, however, remained unchanged and was managed separately. ⚠️ Limitations: case report (n=1), level of evidence 5, result not generalisable and causality not demonstrable, final follow-up conducted by telephone. The authors put forward three hypotheses, without deciding between them, for knee pain of lumbar origin: altered dynamic alignment of the spine, contribution of the L4 root and of the anterior innervation of the knee, or a hypoalgesic effect of spinal loading.

Clinical lessons :

  1. Chronic or recurrent patellar pain calls for assessment of the extended kinetic chain (ankle, hip, but also the lumbopelvic spine), all the more so in a patient who reports a history of lumbar problems.
  2. The MDT/McKenzie approach was enough here, in four sessions, to reveal a directional preference for extension that redirected the entire therapeutic strategy.
  3. The psychosocial components (kinesiophobia, catastrophising) must remain present in the background (Mallows 2017).⁴
“Recalcitrant patellar tendinopathy demands diagnostic humility. The tendon is rarely the only culprit: the kinetic chain, the spine, beliefs and the sporting context co-construct the persistence of pain. An HSR programme is worthless if the patient lands in valgus, fears jumping, or if the pain partly comes from elsewhere.”

Critique and controversy: where do clinical cases sit in the hierarchy of evidence?

🧠 Clinical cases are fundamental for generating hypotheses and reporting rare presentations, but their level of evidence is the lowest in the entire scientific hierarchy. A single case illustrates a possibility, not a general rule. It cannot control for placebo, regression to the mean or spontaneous evolution.⁹ Publication bias is massive (failures are rarely published).

📐 Hierarchy of scientific evidence: where does each type of study belong?

Strength of evidence decreasing from top (meta-analyses) to bottom (isolated cases)

LEVEL
1a
Meta-analyses & systematic reviews of RCTs
E.g.: Challoumas 2021 NMA · Nutarelli 2023 SR/MA epidemiology · Sprague 2018 SR risk factors · Acebes-Hueto 2024 SR
LEVEL
1b
Randomised controlled trials (RCTs)
E.g.: Breda 2021 PTLE vs ECC · Kongsgaard 2009 HSR · Rio 2015 isometrics · Silbernagel 2007 pain monitoring (Achilles)
LEVEL
2
Prospective cohort studies
E.g.: Backman 2011 junior basketball cohort · Hägglund 2011 UEFA cohort · Kettunen 2002 15-year follow-up
LEVEL
3
Case-control & cross-sectional studies
E.g.: Lian 2005 prevalence in elite athletes · Mendonca 2018 hip/foot factors · Bisseling 2008 landing
LEVEL
4
Case series
E.g.: small surgical series · non-randomised pre/post ESWT series
LEVEL
5
Case reports (n=1) & expert opinion
E.g.: Petrolo 2022 case report · Serres 2025 MDT case report · expert opinions

A simplified GRADE / Oxford CEBM hierarchy. The length of the coloured bar on the right illustrates the relative strength of evidence. Practical implication: when an appealing clinical case and a meta-analysis diverge, the decision should follow the meta-analysis. Clinical cases remain valuable for generating hypotheses, reporting rare presentations, or illustrating a clinical reasoning process.

A persistent controversy in patellar tendinopathy is the exact place of imaging. The poor correlation between symptoms and structural abnormalities (thick asymptomatic tendons) argues for sparing use, but routine practice remains very “image-dependent”: over-prescription of ultrasound, therapeutic decisions based on the image rather than on the clinical picture. McAuliffe 2016 (SR/MA) showed that the predictive value of imaging for the development of symptoms is insufficient in practice.⁵ Treat the patient, not the image. Another controversy concerns the publication bias of experimental protocols (multiple PRP injections, prolotherapy, polidocanol, embolisation). Successes are published, failures stay in the drawer. Clinicians must be particularly wary of “miracle new techniques” without solid aggregated data. On PRP, the Challoumas 2021 NMA keeps progressive exercise as first line while the Andriolo 2019 SR/MA judges multiple injections worth considering: two opposite readings of a low-quality literature.⁶,⁷ Finally, the heterogeneity of patients makes generalisation hazardous. A PTLE protocol that is effective in a motivated 22-year-old volleyball player may be unsuitable for an adolescent in a growth spurt, a recreational athlete who has become sedentary or a female patient with a dominant psychological component. A clinical stratification (sporting intensity, age, psychosocial profile, comorbidities) remains to be developed, but already guides decision-making.

⭐ Key points

  • The case reported by Petrolo 2022 (J Can Chiropr Assoc, PMID 36275082) illustrates the common diagnostic error: in an adolescent footballer, a meniscal tear seen on MRI wrongly led to a diagnosis of meniscal lesion, whereas the pain was due to patellar tendinopathy, which resolved in 6 weeks of progressive rehabilitation. Treat the patient, not the image.
  • The case reported by Serres 2025 (PMC12129631) shows that pain at the inferior pole of the patella, in a 45-year-old marathon runner, can stem from a lumbar derangement identifiable by MDT/McKenzie: with repeated lumbar extensions alone, the VISA-P went from 57/100 to 99/100. An argument for assessing the extended kinetic chain.
  • Critical differential diagnoses : meniscal lesion, patellofemoral pain syndrome, synovial plica, Hoffa's disease, Sinding-Larsen-Johansson (child), Osgood-Schlatter (adolescent), avulsion fracture of the inferior pole, partial ACL injury, prepatellar bursitis.
  • The kinetic chain (ankle dorsiflexion, hip strength/activation, landing mechanics) must be assessed systematically (Mendonca 2018, Backman 2011, Bisseling 2008).
  • The psychosocial factors (kinesiophobia, catastrophising; Mallows 2017) influence the trajectory and must be addressed.
  • ⚠️ Level of evidence : a case report = level 5 (the weakest). In case of divergence, follow the meta-analyses (level 1a), not the isolated case. Cases illustrate; they do not demonstrate.
Bibliography
  1. Petrolo A. Meniscal lesion or patellar tendinopathy? A case report of an adolescent soccer player with knee pain. J Can Chiropr Assoc. 2022;66(2):157-171. PMID 36275082.
  2. Crossley KM, Stefanik JJ, Selfe J, et al. 2016 Patellofemoral pain consensus statement from the 4th International Patellofemoral Pain Research Retreat. Br J Sports Med. 2016;50(14):839-843. PMID 27343241.
  3. Serres W, Van Cant J. Patellar Tendinopathy Responding to Spinal Treatment: A Case Report Using Mechanical Diagnosis and Therapy. Int J Sports Phys Ther. 2025;20(6):855-863. PMC 12129631.
  4. Mallows A, Debenham J, Walker T, Littlewood C. Association of psychological variables and outcome in tendinopathy: a systematic review. Br J Sports Med. 2017;51(9):743-748. PMID 27852585.
  5. McAuliffe S, McCreesh K, Culloty F, Purtill H, O'Sullivan K. Can ultrasound imaging predict the development of Achilles and patellar tendinopathy? A systematic review and meta-analysis. Br J Sports Med. 2016;50(24):1516-1523. PMID 27633025.
  6. Challoumas D, Pedret C, Biddle M, et al. Management of patellar tendinopathy: a systematic review and network meta-analysis of randomised studies. BMJ Open Sport Exerc Med. 2021;7(4):e001110. PMID 34900334.
  7. Andriolo L, Altamura SA, Reale D, et al. Nonsurgical Treatments of Patellar Tendinopathy: Multiple Injections of Platelet-Rich Plasma Are a Suitable Option. Am J Sports Med. 2019;47(4):1001-1018. PMID 29601207.
  8. Mendonça LD, Ocarino JM, Bittencourt NFN, Macedo LG, Fonseca ST. Association of hip and foot factors with patellar tendinopathy (jumper's knee) in athletes. J Orthop Sports Phys Ther. 2018;48(9):676-684. PMID 29792104.
  9. Nissen T, Wynn R. The clinical case report: a review of its merits and limitations. BMC Res Notes. 2014;7:264. PMID 24758689.
  10. Breda SJ, Oei EHG, Zwerver J, et al. Effectiveness of progressive tendon-loading exercise therapy in patients with patellar tendinopathy: a randomised clinical trial. Br J Sports Med. 2021;55(9):501-509. DOI 10.1136/bjsports-2020-103403.
  11. Bisseling RW, Hof AL, Bredeweg SW, Zwerver J, Mulder T. Are the take-off and landing phase dynamics of the volleyball spike jump related to patellar tendinopathy?. Br J Sports Med. 2008;42(6):483-489. PMID 18385187.
  12. Backman LJ, Danielson P. Low range of ankle dorsiflexion predisposes for patellar tendinopathy in junior elite basketball players: a 1-year prospective study. Am J Sports Med. 2011;39(12):2626-2633. PMID 21917610.
  13. Kettunen JA, Kvist M, Alanen E, Kujala UM. Long-term prognosis for jumper's knee in male athletes. A prospective follow-up study. Am J Sports Med. 2002;30(5):689-692. PMID 12239003.

How do you apply these recommendations concretely in your practice?

In this chapter: specific red flags (patellar tendon rupture, avulsion fracture, infection, tumour process, meniscal lesion), referral criteria, PROMs and the VISA-P score, barriers to and facilitators of evidence-based implementation.

Applying the recommendations in routine practice remains the weak link in the evidence-based chain. Knowing what to do (Breda 2021, Challoumas 2021 NMA, Malliaras 2015) is not the same as knowing how to apply it with each patient, given their time constraints, preferences and comorbidities. 🧑‍⚕️

When and to which other healthcare professionals should you refer?

The first, non-negotiable step of triage is screening for red flags. Clinicians should have a low threshold for referral: sensitivity takes precedence over specificity when serious conditions are at stake.

🚩 Red flags specific to the patellar region

  • Patellar tendon rupture : audible/felt “pop” after a powerful jump + loss of active knee extension + acute pain + sometimes a palpable defect above the tibial tuberosity. Orthopaedic emergency (ultrasound + MRI).
  • Avulsion fracture of the inferior pole of the patella : after acute trauma, exquisite tenderness on palpation, inability to extend fully. Lateral radiograph + MRI.
  • Meniscal lesion : anteromedial pain, positive McMurray, joint locking, SLDS rarely reproduces the pain. MRI if suspected, always comparing the image with the clinical findings (Petrolo 2022).¹
  • Infection (cellulitis, septic prepatellar bursitis, septic arthritis) : fever + warm swelling + exquisite pain + rapidly spreading erythema. Emergency.
  • Tumour process (rare but to be considered): palpable mass of progressive onset, night pain, night sweats, unexplained weight loss, deterioration in general condition. MRI + blood tests.
  • Systemic rheumatological disease : spondyloarthritis (multiple enthesitis, HLA-B27, morning axial stiffness, uveitis), early rheumatoid arthritis, gout (acute attack). Blood tests (FBC, CRP, anti-CCP, HLA-B27).
  • Sinding-Larsen-Johansson disease (child aged 10-13) or Osgood-Schlatter (adolescent aged 11-15): pain at the tip of the patella or at the tibial tuberosity during a growth spurt. Lateral radiograph.
  • Recent treatment with fluoroquinolones or long-term systemic corticosteroids + acute tendon pain: increased risk of rupture, alert the prescribing doctor.

⚠️ Any red flag → prompt medical referral (GP, emergency department, sports physician, orthopaedic surgeon) before or alongside physiotherapy management.

Beyond emergencies, yellow flags (psychosocial factors of failure) justify a broader approach. The Mallows 2017 review (BJSM) identifies high kinesiophobia, catastrophising and low self-efficacy as major predictors of chronicity.² In these cases, consider collaborating with a psychologist specialising in chronic pain, and integrate a cognitive-behavioural approach into the rehabilitation programme. Interprofessional collaboration is required for complex profiles:

  • Sports physician / general practitioner : full work-up, management of comorbidities, overall follow-up.
  • Orthopaedic surgeon / knee surgeon : failure ≥ 6 months of structured conservative treatment, suspected complex intratendinous lesion, avulsion fracture, meniscal lesion (Everhart 2017).³
  • Interventional radiologist : for the rare refractory cases in which ultrasound-guided injections (PRP) are considered through shared decision-making, despite the limited evidence.
  • Podiatrist / pedorthist : biomechanical analysis of jumping and landing, insoles if necessary (rare), footwear advice.
  • Coach / strength and conditioning coach / club staff : review and restructuring of the training programme (jump volume, periodisation, recovery) to manage load in the long term.
  • Psychologist specialising in pain : persistent kinesiophobia, catastrophising, context of widespread chronic pain.

How do you measure outcomes and overcome barriers to implementation?

📊 Measuring outcomes is the sine qua non of quality practice. The VISA-P score (Visentini 1998) remains the reference PROM tool for patellar tendinopathy, validated internationally.⁴ Although there is not yet a Core Outcome Set specific to patellar tendinopathy (unlike the 2024 COS-AT for the Achilles tendon), there is consensus on the essential outcomes:

Essential outcomes in patellar tendinopathy :

  • Pain : numeric rating scale (NRS) 0-10, measured at rest, on the SLDS and during activities.
  • Function and severity : VISA-P, 8 questions, score 0-100. MCID ≈ 13-15 points.⁴
  • Participation : return to sporting activities, level of practice vs before the injury.
  • Quality of life : EQ-5D or similar.
  • Global rating of change by the patient (PGIC).
  • Quadriceps strength and symmetry: hand-held or isokinetic dynamometry.

Integrating these PROMs into routine practice comes up against documented barriers: lack of time (the most common), lack of suitable IT tools, lack of training in interpretation, the perception that it is “administrative” rather than clinically useful.

Implementation strategies to overcome these barriers:

  • Digital tools : a tablet or smartphone app that the patient fills in in the waiting room, automatic calculation of the VISA-P score, graphical display of progress.
  • Continuing education : practical workshops on using PROMs and on shared decision-making.
  • Integration into routine : VISA-P at every follow-up visit (every 4-6 weeks), not only at the start and end of care.
  • Shared decision-making : present the options to the patient (PTLE vs HSR vs isolated ECC), discuss the pros and cons (weekly volume, equipment, sporting calendar), decide together. This significantly increases adherence and satisfaction.

Critique and controversies: beyond the guidelines

The red flag paradox still holds: no single sign taken in isolation has a high positive predictive value. It is the cluster of findings + probabilistic clinical reasoning that guide referral, not a checklist. The risk is twofold: over-diagnosing (sending every pain for an MRI) or under-diagnosing (missing an avulsion fracture or a meniscal lesion by attributing the pain to a simple tendinopathy). The Petrolo 2022 case is a reminder of the mirror-image risk: over-interpreting an image and considering meniscal surgery for pain that came from the tendon.¹ The “knowing-doing” gap is particularly striking in patellar tendinopathy: the Challoumas 2021 NMA confirmed the lack of superiority of PRP as monotherapy and the primacy of progressive exercise, the Breda 2021 RCT found, in a single trial, PTLE better than isolated decline eccentric exercise, and yet routine practice sometimes still imposes a single eccentric protocol or prescribes costly PRP injections without indication.⁵,⁶ Moving to genuine EBP requires more than disseminating information: it requires an overhaul of economic incentives and of continuing education. Finally, the tension between standardisation and personalisation is central. The VISA-P and functional criteria are essential for comparability, but the clinician must know how to adapt the programme to the patient's profile (high-level athlete, recreational athlete who has become sedentary, growing adolescent, patient with a dominant psychological component).

Key points

  • Referral is crucial for safety : red flags (patellar tendon rupture, avulsion fracture, meniscal lesion, infection, tumour process) → prompt medical referral.
  • Psychosocial yellow flags (kinesiophobia, catastrophising; Mallows 2017) → collaboration with a psychologist, biopsychosocial approach.
  • Measure outcomes with the VISA-P score (Visentini 1998): 8 questions, 0-100, MCID 13-15 points.
  • The VISA-P at every follow-up (every 4-6 weeks), not only at the start/end.
  • For cases refractory after 12 weeks of PTLE/HSR: reconsider the diagnosis (imaging), assess the kinetic chain (chap. 5), discuss ESWT as an adjunct, and possibly a surgical opinion after 6 months of structured conservative care.
  • The shared decision-making approach (presenting PTLE vs HSR, discussing according to preferences) increases adherence and satisfaction.
Bibliography
  1. Petrolo A. Meniscal lesion or patellar tendinopathy? A case report of an adolescent soccer player with knee pain. J Can Chiropr Assoc. 2022;66(2):157-171. PMID 36275082.
  2. Mallows A, Debenham J, Walker T, Littlewood C. Association of psychological variables and outcome in tendinopathy: a systematic review. Br J Sports Med. 2017;51(9):743-748. PMID 27852585.
  3. Everhart JS, Cole D, Sojka JH, et al. Treatment Options for Patellar Tendinopathy: A Systematic Review. Arthroscopy. 2017;33(4):861-872. PMID 28110807.
  4. Visentini PJ, Khan KM, Cook JL, et al. The VISA score: an index of severity of symptoms in patients with jumper's knee (patellar tendinosis). J Sci Med Sport. 1998;1(1):22-28. PMID 9732118.
  5. Challoumas D, Pedret C, Biddle M, et al. Management of patellar tendinopathy: a systematic review and network meta-analysis of randomised studies. BMJ Open Sport Exerc Med. 2021;7(4):e001110. PMID 34900334.
  6. Breda SJ, Oei EHG, Zwerver J, et al. Effectiveness of progressive tendon-loading exercise therapy in patients with patellar tendinopathy: a randomised clinical trial. Br J Sports Med. 2021;55(9):501-509. DOI 10.1136/bjsports-2020-103403.
  7. Malliaras P, Cook J, Purdam C, Rio E. Patellar Tendinopathy: Clinical Diagnosis, Load Management, and Advice for Challenging Case Presentations. J Orthop Sports Phys Ther. 2015;45(11):887-898. PMID 26390269.
  8. Theodorou A, Komnos G, Hantes M. Patellar tendinopathy: an overview of prevalence, risk factors, screening, diagnosis, treatment and prevention. Arch Orthop Trauma Surg. 2023;143(11):6695-6705. PMID 37542006.
  9. Andriolo L, Altamura SA, Reale D, et al. Nonsurgical Treatments of Patellar Tendinopathy: Multiple Injections of Platelet-Rich Plasma Are a Suitable Option. Am J Sports Med. 2019;47(4):1001-1018. PMID 29601207.
  10. Charles R, Fang L, Zhu R, Wang J. The effectiveness of shockwave therapy on patellar tendinopathy, Achilles tendinopathy, and plantar fasciitis: a systematic review and meta-analysis. Front Immunol. 2023;14:1193835. PMID 37662911.
  11. Kongsgaard M, Kovanen V, Aagaard P, et al. Corticosteroid injections, eccentric decline squat training and heavy slow resistance training in patellar tendinopathy. Scand J Med Sci Sports. 2009;19(6):790-802. PMID 19793213.
  12. Rio E, Kidgell D, Purdam C, et al. Isometric exercise induces analgesia and reduces inhibition in patellar tendinopathy. Br J Sports Med. 2015;49(19):1277-1283. PMID 25979840.
  13. Nutarelli S, da Lodi CMT, Cook JL, Deabate L, Filardo G. Epidemiology of Patellar Tendinopathy in Athletes and the General Population: A Systematic Review and Meta-analysis. Orthop J Sports Med. 2023;11(6):23259671231173659. PMID 37347023.

What next, after reading this?

This article is part of a collection of evidence-based clinical syntheses. A question, a comment, a correction to suggest? Contact us directly through the WhatsApp button at the bottom right of the screen.

Behind this article

An author who explains, a reviewer who checks.

How we write and check our content

Anthony Baillon, physiotherapist and co-founder of Physio Learning
✍️ Author

Anthony Baillon

Physiotherapist · co-founder of Physio Learning

Marked for life by his first four-hour lecture without a single image, he took a master’s in instructional design so that it would never happen to anyone again. He hunts down publication bias and unreadable slides with the same intransigence.

PhysiotherapistInstructional designerCare design
Follow on LinkedIn
Robin Vervaeke, head of scientific content at Physio Learning✓ Verified

Robin Vervaeke

Scientific lead

Physiotherapist specialising in neuro-musculoskeletal practice and holder of a master’s in public health. He checks the methodological rigour of every article: primary sources, levels of evidence, no exceptions.

Neuro-musculoskeletalM2 Public health
Follow on LinkedIn

Share